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DEFINITIONS
Activity-based anorexia (ABA)

a condition in which subjects maintained on a food
restriction schedule and given free access to running
wheels display hypophagia, rapid body weight loss,
and increased running wheel activity

Anorexia

a loss of appetite especially when prolonged

Anorexia nervosa (AN)

a serious eating disorder that is characterized by a
pathological fear of weight gain leading to faulty
eating patterns, malnutrition, and usually excessive
weight loss

Activity-stress ulcer

a symptomatic model of anorexia nervosa and
obsessive-compulsive disorder as well as peptic
ulcer; models similar to activity-based anorexia

Bulimia nervosa (BN)

an eating disorder in which a person regularly
binges and then uses laxatives, induces vomiting,
fasts, or uses extreme exercise in order to prevent
weight gain

Cachexia

general physical wasting and malnutrition usually
associated with chronic disease

Eating disorders not
otherwise specified (EDNOS)

an eating disorder in which the patient meets some
but not all of the criteria of another eating disorder

Obesity

being 20% above the IBW or a BMI of >30

Overweight

being 10-20% above the ideal body weight (IBW)
or a body mass index (BMI) of 25-29

Glycemic index

a score to measure the effect of individual foods on
blood glucose levels

Resistant starch (RS)

a type of starch that is resistant to the effects of
digestive enzymes and is not digested in the small
intestine; when consumed, resistant starch functions
much like fiber in the human diet
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ABSTRACT
Anorexia nervosa is the third most common illness among adolescent females.
Approximately one half the cases of anorexia nervosa have been suggested to be activityinduced. Various animal studies have been used to study human anorexia, particularly
the activity-based anorexia model (ABA). The ABA paradigm consists of diet restriction
and liberal access to activity, which ultimately results in a rapid decrease in both body
weight and food intake paradoxical to the significant increase in activity. Because
resistant starch (RS) has been shown to initiate a lower rise and a steady level of postprandial blood glucose, it was hypothesized that a diet containing RS would reduce the
severity of the anorexia associated with the ABA model. In this study, 56 five-wk old
male Sprague-Dawley rats were assigned to 8 groups. Animals were fed a control diet
(C-diet) or a RS-diet, on an ad libitum or a restricted-feeding (one 90min meal per day)
schedule, and allowed 22-hr of access or no access to activity wheels. The study ended
when a majority of the ABA rats reached <75% of their pre-experimental body weights.
Within 4 days of the experiment, ABA rats on the RS-diet lost an average 66g of body
weight compared to an average loss of 31g in the C-diet (p<0.01). ABA rats on the RSdiet ran 31% more (NS), despite consuming 30% fewer calories per kg body weight, than
those on the C-diet (p<0.01). ABA rats fed the RS-diet had 3.97 times higher levels of
plasma norepinephrine (NE) compared to their associated controls (p<0.0001); ABA rats
fed the C-diet had only 1.4 times the NE level of their corresponding controls (NS). All
RS-fed rats had an average of 17-50% less fat pad (brown, perirenal, epididymal, &
retroperitoneal) weights compared to C-fed rats (p<0.02). Resistant starch exacerbates
rather than mitigates the responses to the ABA paradigm.
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CHAPTER 1
INTRODUCTION
In the U.S., the high availability of various foods, the sedentary lifestyles, and
society’s standards for the ideal image in men (Leit, Gray, & Pope, 2002) and women
(Groesz, Levine, & Murnen, 2002) have lead to a wide range of nutritional
complications. For example, the public encountered and continues to struggle with the
problem of obesity. More than sixty percent of the U.S. population is either overweight
or obese (Must et al., 1999), and the prevalence of children with obesity is increasing
(Birch & Fisher, 1998). Overweight is defined as being 10-20% above the ideal body
weight (IBW) (Forsythe, 1998) or a body mass index (BMI) of 25-29 (Laquatra, 2000).
Obesity is defined as being 20% above the IBW (Forsythe, 1998) or a BMI of >30
(Laquatra, 2000). The medical consequences of obesity include, but are not limited to,
increased risks of cardiovascular diseases, joint diseases, gall bladder diseases, cancer,
diabetes, hypertension, lipid disorders, and gout (Forsythe, 1998; Laquatra, 2000; Must et
al., 1999).
On the other hand, there are people who are struggling with severe underweight
and eating disorders, both of which can eventually lead to a complex state of malnutrition
or death if left untreated. Eating disorders are considered a physiological or a
psychological problem, depending on the disorder. One of the most common types of
eating disorders is anorexia nervosa. Anorexia nervosa (AN) is an eating disorder
characterized by the failure to maintain a body weight within 15% of one’s IBW,
distorted food beliefs or food aversions, intense fear and refusal of gaining weight,
excessive weight loss, amenorrhea in females, and sometimes obsessive activity.
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Individuals with AN have a distorted body image, that is, they perceive themselves as
being overweight despite their emaciated status, and they are often in denial of their
condition (Forsythe, 1998; Schebendach & Reichert-Anderson, 2000). However, it is
well worth stating that the literal meaning of anorexia is the loss of appetite, especially
when prolonged.
Anorexia nervosa can lead to many medical outcomes that include a weakened
immune system, anemia, delayed gastric emptying, organ damages, irregular heartbeats,
changes in the central nervous system, low body temperatures, low blood pressures,
pubertal delay in children, and the disruption of menstrual cycles in females
(Schebendach & Reichert-Anderson, 2000). It has been estimated that approximately 6%
of anorexics die from anorexia nervosa (Forsythe, 1998). If AN is detected and treated
early in the disorder, there can be a decline in the mortality rate by 10%, and up to 80%
of the involved individuals may either fully or partially recover (Becker, Grinspoon,
Klibanski, & Herzog, 1999).
Past research suggested that one in every 800-1000 females are associated with
anorexia nervosa, but it is now estimated that one out of every hundred young females
have the disorder (Forsythe, 1992). The most common period of onset seems to be
during adolescence (Schebendach & Reichert-Anderson, 2000). Girls between the ages
of 9-14 have reported a desire to be thinner and have attempted dieting (Halvarsson,
Lunner, Westerberg, Anteson, & Sjoden, 2002). More attention is given to females
because the majority of the reported cases are primarily females; however, the rate of
incidence in males is increasing (Forsythe, 1998). Males account for approximately 510% of all eating disorders (Carlat, Camargo, & Herzog, 1997), and it is suggested that
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incidences for males are lower tha n that for females because males tend to be less
dissatisfied about their weight (Sisson, Franco, Carlin, & Mitchell, 1997). Other
researchers, however, have reported findings that males were more disturbed about their
weight than females (Sorbara & Geliebter, 2002). Nevertheless, whether males or
females are more displeased about their weights, it has been strongly indicated that the
media plays a large role in rendering the negative perception about body size, shape and
weight (Groesz et al., 2002; Leit et al., 2002).
A common characteristic of individuals with anorexia nervosa is increased
physical activity. Furthermore, it has been suggested that this increase in activity is one
of the first signs to appear abnormal and one of the last few to normalize (Kron, Katz,
Gorzynski, & Weiner, 1978). Therefore, the proposed study is designed to model the
anorexia found in highly active individuals. Because the weight loss of anorexia can be
attributed in part to the combination of low energy intakes and high-energy expenditures,
there must be a way to ameliorate the weight loss effect—if not entirely preventing it
from occurring. The best probable alternative may be to prolong the progression to
anorexia, rather than solely attempting to reverse it.
In the proposed study, young male rats are subjected to the standard activitybased anorexia (ABA) model that consisted of a simultaneous exposure to restricted
feeding schedules and liberal access to running wheels. Activity-based anorexia (ABA)
can be defined as the reduction of food intake and a progressive loss of body weight that
is paradoxical to an increase in wheel running. In the intended study, it was predicted
that the rats would continue to run while their food intake is decreased. Because there is
no compensation for the energy expended on the running wheels, the rats will continue to
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lose weight. The result of this procedure, if allowed to continue for several days, can
lead to severe loss of body weight and eventual death if the rats are not removed from the
experiment. ABA has clinical significance because some patients with anorexia nervosa
often use intense exercising and diet restriction as a means of losing weight and
maintaining the weight loss (C. Davis, Kennedy, Ravelski, & Dionne, 1994; Kron et al.,
1978).
Objective and Hypothesis
The objective of this study is to determine whether the outcomes of the activitybased anorexia (ABA) paradigm can be attenuated if the diet contained resistant starch.
It is hypothesized that if the animals are fed a diet containing resistant starch while
exposed to the standard ABA procedure, the effects of the ABA model will be
ameliorated.
Rationale and Justification
A high glycemic diet produces transient post-prandial hyper- and hypo-glycemia.
Conversely, because animals fed a resistant starch, which has a low glycemic index,
slowly digest and absorb glucose, they are able to maintain euglycemia for a longer
period of time when compared to those fed a high glycemic index diet (Raben, Kiens, &
Richter, 1994). Because euglycemia is sustained over a longer time frame, there should
be less, if any, stimulation of catabolic hormone release, and thus, energy stores will not
be catabolized. Higher body stores of energy (e.g., fat, protein, glycogen) are suggested
to attenuate wheel running associated with ABA (Fish & Lewis, 1996); therefore, it is
possible that a resistant starch diet may attenuate the outcomes of ABA.
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Assumptions
1. The activity-based anorexia paradigm is an acceptable model of human anorexia.
2. The blood and tissue collections from the animals are representative of humans.
3. The animals are free from any diseases or disorders that may affect the results.
4. The design of the run-test(s) will allow appropriate determination for the
assignment of animals to specified groups.
Limitations
1. Psychological issues, whic h are evident in human anorexia nervosa, cannot be
evaluated in rats, thus the model lacks psychological representation of this
disorder.
2. Possible gender differences were not identified because experiment(s) did not
simultaneously consist of both male and female rats due to limited laboratory
space and equipment.
3. The number of animals used may not be sufficient to generate a reliable
conclusion.
4. The intensity, frequency, and duration were not measured due to lack of
equipment and programs.
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CHAPTER 2
REVIEW OF LITERATURE
Societal influences have put a great deal of pressure on its people. Overemphasis
on health, fitness, beauty, and achievements has caused many to be at harm. For
example, males and females struggle to be thin and fit in order to adhere to the standard
of the ideal man or woman (Silverstein & Perdup, 1998). Athletes in competitive sports
strive to be at certain body weights in order to compete at their maximum potential
(Stoutjesdyk & Jevne, 1993). Military soldiers are expected to put great effort in
reaching or maintaining body weight within strict standards. A report by McNulty (1996)
indicated that many people in the U.S. Army, Navy, Marines, and Air Force were
discharged or failed to get a promotion because they were overweight (McNulty, 2001).
In a study by Rose et al. (1993), Army soldiers indicated that appearance, health
concerns, and upcoming weigh-ins were the primary reasons for attempting weight loss
(McNulty, 2001). However, there is danger when dieting individuals develop eating
disorders. They may become emotionally obsessive about their appearance, which may
result in abnormal eating patterns (i.e., binging, purging, starving) or abnormal exercising
routines to a point of severe malnourishment and physiological and psychological
complications (Becker et al., 1999; Rock, 1999).
Eating disorders affect people of all ages, especially adolescent females, for
whom it is the third most common chronic illness (Kreipe & Birndorf, 2000). Over five
million Americans suffer from some form of eating disorder (Adolescent Medicine
Committee & Canadian Paediatric Society, 1998). Research shows that more females are
reported to have eating disorders than are males, who make up only 5-10% of the
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population with eating disorders (Carlat et al., 1997). In addition, there is a higher
prevalence among explicit groups in which diet restriction and regulation of body weight
is of great importance (e.g., ballerinas, dancers, marathon runners, or models) (Carlat et
al., 1997; Engstrom et al., 1999). Because eating disorders are more than merely medical
complications, they are usually treated with the help of an interdisciplinary team (e.g.,
medical professionals, nurses, dietitians, and psychiatrists), family, relatives, and close
friends (Adolescent Medicine Committee & Canadian Paediatric Society, 1998).
Examples of eating disorders include, but are not exclusive to, anorexia nervosa
(AN), bulimia nervosa (BN), and eating disorders not otherwise specified (EDNOS).
EDNOS is a less severe form of AN and BN that is estimated to occur in approximately
1-2% of the population and makes up 50% of all eating disorders. An individual with an
eating disorder is classified as having EDNOS if he or she has not met all the criteria of
any specific eating disorder. For example, in the fourth edition of Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV-TR), a female is diagnosed with having
EDNOS if she has met all criteria for AN but continues to have regular menses. EDNOS,
however, can develop into AN or BN if left undiagnosed and untreated (Spear &
Stellefson, 2001).
Bulimia nervosa is an eating disorder characterized by repeated episodes of
binging with subsequent purging and feelings of guilt. Unlike anorexia nervosa,
individuals with BN are usually at normal or above normal weights. According to the
DSM-IV-TR, in order to be diagnosed with BN, an individual (1) must have “recurrent
episodes of binge eating” and a “recurrent inappropriate compensatory behavior,” in an
attempt to prevent weight gain, for at least twice a week for a period of three months; (2)
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must evaluate his or her self by means of body shape and weight; and (3) must not be
diagnosed with anorexia nervosa. BN occurs in 2-5% of the population (Spear &
Stellefson, 2001).
Anorexia nervosa is a psychiatric disorder in which individuals have distorted
body images, even if underweight, and have distorted food beliefs. The individuals are
usually <85% of their ideal body weight (IBW) or have a body-mass index (BMI) of
<17.5 (Becker et al., 1999). The DSM-IV-TR states that to be diagnosed as having AN,
one must (1) refuse to maintain body weight at or above standard weight for one’s age
and height; (2) have an intense worry of weight gain or fat gain even if one is under
weight; (3) have a distorted body image; and (4) have amenorrhea if she is postmenarcheal (Spear & Stellefson, 2001). AN is the only psychiatric disorder that requires
a biological abnormality (i.e., amenorrhea) for diagnosis in females (C. Davis, 1997).
Death from AN is usually due to starvation, suicide, or electrolyte imbalance (McNulty,
2001).
Many health complications result from eating disorders. For example, in AN,
symptoms can range from brittle hair and nails, dry skin, severe constipation,
hypoglycemia, and hypotension to bradycardia, delayed gastric emptying, osteoporosis,
and other cardiovascular complications (e.g., reduced heart mass) (Bachrach, Guido,
Katzman, Litt, & Marcus, 1990; Becker et al., 1999; Cooke & Chambers, 1995; Fisher et
al., 1995; Kreipe & Birndorf, 2000; Rock, 1999; Swenne, 2000; Webb, Kiess, & ChanYan, 1986). In addition, BN symptoms include gastrointestinal problems, esophageal
reflux disease, muscle weakness, fatigue, cardiac arrhythmias, dehydration, electrolyte
imbalances, and dental erosion (Mitchell, Hatsukami, Eckert, & Pyle, 1985; Rock, 1999).
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Furthermore, in any of the eating disorders the medical complications may be deemed
irreversible (i.e., retarded growth or hindered puberty) if the individual is not diagnosed
and treated (Abrams et al., 1993; Fisher et al., 1995).
Human Studies
In 1997, 1.1% of the active duty U.S. female Navy nurses who participated in a
study were diagnosed with anorexia nervosa, which was comparable to the incidence of
AN in the U.S. national population (McNulty, 1997a). However, researchers found that
the incidence of BN was six times greater for the Navy nurses than that of the U.S.
population. Another study in 1997 showed that there was a 2.5% and 6.8% incidence of
AN and BN, respectively, in a study of 4,800 Navy men (McNulty, 1997b).
Edholm and associates reported that cadets ingest less food on days of military
drilling than they do on days of lower activity (Edholm, Fletcher, Widdowson, &
McCance, 1955). In a correlational study of 1,278 anonymous females in the armed
services (U.S. Army, Navy, Air Force, and Marines in Okinawa, Japan), surveys showed
that body fat averaged 19.5% for the total sample and amenorrhea was significantly
higher among members of the Marines—this was found to reflect the youngest
population. The Marines also reported the highest use of diet pills and laxatives and the
highest rate of vomiting. Participants indicated increased episodes of binging or purging
during the biannual Physical Readiness Test (PRT). The surveys showed that the most
frequently used method for attaining one’s appropriate weight was fasting, followed by
binging and the use of diet pills (McNulty, 2001).
Reports suggest that much of human anorexia may be activity-induced (Crisp,
Hsu, Harding, & Hartshorn, 1980; C. Davis et al., 1994; King, Burley, & Blundell, 1994).
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Exercise has been known to reduce weight in some individuals and possibly the amount
of food consumption per day if all other factors (e.g., age, sex, diet, duration and intensity
of exercise) are taken into account (Durrant, Royston, & Wloch, 1982; Pi-Sunyer & Woo,
1985; Thompson, Wolfe, & Eikelboom, 1988). Nonetheless, the connection between
activity and food consumption primarily contributes to the balance of energy (King et al.,
1994). The effects of exercise on energy intake in normal-weight young people (10 men
and 10 women) were examined. Participants were given a diet individualized to their
needs and were randomly assigned to either an exercising group (1 hour/day of treadmill
at ~68% of VO2max for five days) or to a sedentary group (no treadmill exercise).
Although there was a significant increase in caloric intake by exercising men and no
significant increase for exercising women, all the active participants were in negative
energy balance during the exercise period (Staten, 1991).
In another study, the effect of intensity and duration of exercise on energy
consumption was studied in twenty-three healthy male participants. In part one of the
study, the participants were assigned to a control group, a low-intensity exercising group,
or a high-intensity exercising group. In part two of the study, participants were assigned
to a short-duration exercising group, a high-duration exercising group, or a control group.
In part one, there was no reduction of hunger in those in the low-intensity group at any
time. Conversely, there was a short-lived suppression of hunger during exercise and 15
minutes immediately following exercise for those in the high-intensity group. There was
no effect on total caloric consumption among any groups. In part two, there was a
significant decrease in hunger during both the short- and long-duration exercise periods.
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In addition, hunger suppression continued after exercising with the greatest suppression
for those in the long-duration exercise treatment (King et al., 1994).
Animal Models
Animal models of anorexia have been used for nearly 50 years (J. F. Hall &
Hanford, 1954). Many animal studies used rats as a model for human anorexia, but the
animal paradigm has also been performed with mice (Epling, Pierce, & Stefan, 1983),
hamsters, gerbils, and guinea pigs (Vincent & Pare, 1976). It was Epling and co-authors
who coined the term “activity-based anorexia” and proposed a link between anorexia in
animals to anorexia nervosa in humans (Epling et al., 1983). However, activity-based
anorexia may also be referred to as “self-starvation” (Routtenberg & Kuznesof, 1967;
Spatz & Jones, 1971) or “activity-stress” procedures (Pare & Houser, 1973). The former
was the original name given to this paradoxical effect and the latter is usually used in the
context of studies focusing on stomach ulcerations. Therefore, because activity-based
anorexia is a term widely used, it will be used throughout the present literature review to
refer to the negative effects that result from severe food restriction and excessive activity.
Activity-based anorexia (ABA) has been typically characterized by a reduction in
food intake and body weight paradoxically accompanied by a progressive increased
activity level (Dwyer & Boakes, 1997). A standard activity-based anorexia (ABA)
animal model includes simultaneous introduction of diet restriction (one meal for 60-90
minutes per day) and access to running wheels (21-22.5 hours of access per day) to the
animals in the experimental condition. For example, in a study that restricted the
mealtime to 60 minutes per day and allowed access to running wheels for the remainder
of the day, the animals continued to increase their activity, reduce their food intake, and
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lose weight on succeeding days. Over a short period, the animals died because the
amount of calories consumed failed to compensate for the energy expended from the
running (J. F. Hall & Hanford, 1954; Routtenberg & Kuznesof, 1967). A typical rat
would display an initial gradual rise in activity levels and then show a dramatic increase
if the experiment was allowed to continue. Moreover, as activity levels increased (i.e.,
more than 5,000 revolutions per day), the rats’ food intake and body weight declined
considerably (Beneke, Schulte, & vander Tuig, 1995; Epling & Pierce, 1984).
In a study by Tokuyama and lab, rats showed an initial transient reduction in food
intake and a rapid increase in running for the first 5-10 days, followed by an increase in
food consumption that surpassed the amount consumed by the controls (Tokuyama,
Saito, & Okuda, 1982). Studies have shown that experimental rats can run more than 1
km per day (Boakes, 1997) and eat less than 1 gram per day (Routtenberg & Kuznesof,
1967). Thus, as Epling and co-authors state: “animal research on self-starvation suggests
that the combined effects of these variables are multiplicative rather than additive (p. 41)”
(Epling et al., 1983). Much research has been performed in an attempt to determine the
reason behind this phenomenon. Some researchers suggest that the animals drastically
increase their running in order to raise their body temperatures, because animals that fail
to adapt to the restricted feeding schedules were found to have low body temperatures
(Lambert, 1993). Nevertheless, there are many controversial issues such as whether or
not the introduction of both stress factors (i.e., novelty to wheels and deprivation of food)
must be presented simultaneously (Ness, Marshall, & Aravich, 1995), whether females or
males are more vulnerable to this procedure (Boakes & Dwyer, 1997; Doerries, Stanley,
& Aravich, 1991), or whether decreased food intake causes increased running or vice
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versa (Boakes & Dwyer, 1997; Epling & Pierce, 1988; Lett, Grant, Smith, & Koh, 2001).
Because the majority of the experiments prevented running during the feeding period, the
effects of ABA cannot be attributed to the competition between food and activity.
Routtenberg and Kuznesof defined anorexia in the rat as the consumption of less
than 1 gram of food (Routtenberg & Kuznesof, 1967). However, because the older
definition was too rigorous, animals are now classified as being “anorexic” if their body
weight has declined to 70% of their initial body weight, which is the weight loss criterion
used more in the context of activity-stress ulcers (Doerries et al., 1991; Epling & Pierce,
1984). Animals are considered to have reached the “removal” or “starvation” criterion if
they have reached 75% of their pre-experimental body weight on two consecutive days
(Beneke et al., 1995; Boakes, Mills, & Single, 1999). Animals are said to have met the
“recovery” or “survival” criterion when their weight on day 4 is at or above the weight on
day 1 in any consecutive 4-day period (Beneke et al., 1995; Epling & Pierce, 1984).
Pre-existing characteristics such as pre-experimental body weight, age, and
gender seem to play a role in achieving the ABA results. Boakes and Dwyer found that
male rats with low initial body weights (180g on average) lost weight faster than those
with higher initial body weights (205 on average) although all rats were at the same age
(Boakes & Dwyer, 1997). Routtenberg and Kuznesof indicated that rats weighing
approximately 270g at the start of an experiment are highly vulnerable to the ABA effect
(Routtenberg & Kuznesof, 1967). Rieg and associates suggested that an animal with an
initial body weight of more than 350g is less likely to reach a 25% weight loss (Rieg,
Maestrello, & Aravich, 1994). Woods and Routtenberg found that age was a very
important factor in the vulnerability of male rats to ABA. They discovered that younger
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male rats (less than 10 weeks old) lost weight faster than did the older rats (over 10
weeks old). Because the growth rate is quicker for males and especially rapid over the
first 70 days of a rat’s life, maturation is a confounding variable that should be considered
(Woods & Routtenberg, 1971).
Some studies have evaluated gender as another variable in ABA experiments; the
results, however, are lacking consistency. A study by Boakes and co-workers included
two female groups and one male group in an attempt to match age, weight, and gender
factors. One female group (FY; 52 days old; 160g) was age-matched to the male group
(MY; 52 days old; 230g). A second female group (FO; 136 days old; 237g) was weightmatched (mean value of ~230-237g) to the MY group. Results of the study demonstrated
that both age and gender, rather than weight, are strong factors in the standard ABA
procedure; however, age seems to be a more critical aspect in this study. The FY and
MY groups reached the “removal” criteria in an average of 7.0 and 7.4 days, respectively.
However, it took the FO group an average of 10.83 days to reach the removal criteria
(Boakes et al., 1999). These findings are consistent with another lab that found that
female rats are more vulnerable to the effects of diet restriction and excessive activity
than are male rats (Pare, Vincent, Isom, & Reeves, 1978).
In a different study, researchers attempted to match the weights and age for both
male and female rats. In contrast to the findings above, these researchers found that
females ran and ate more than the males, and the male rats lost weight faster than the
female rats, even though the male rats weighed a mean value of 10g more than the female
rats weighed (Doerries et al., 1991). Consistent with this study in some aspects, an even
earlier study evaluated the effects of running and food restriction on male and female
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rats. They found no differences in food consumption and weight changes between
sedentary males and sedentary females. However, they did find that active female rats
recovered from the reduced food intake faster than did the active males. Even though,
the exercising females ran consistently more (a plateau on day 10 of 11,000 revolutions
per day) than did the exercising males (a plateau on day 10 of 4,000 revolutions per day)
throughout the 50-day experiment (Tokuyama et al., 1982).
Roy and Wade found that estrogen is an activity-promoting hormone in both male
and female rats. Their finding supported the argument that females acquire some
characteristics that promote higher activity than do males (E. J. Roy & Wade, 1975). In
another study that attempted to determine whether activity levels and survival rates were
affected by rats (males and females) subjected to gonadectomization and introduced to
the activity-stress (AS) paradigm, researchers found that the castrated animals showed a
reduction in activity but there were no sex differences in activity levels. They also found
that the males survived longer than the females (6.0-6.3 versus 4.1-4.3 days), and the
castrated rats died earlier than the sham-operated rats. Because the animals in the study
were castrated and matched according to age, sex, and weight, it was proposed that when
these three factors are controlled, the difference in vulnerability between males and
females is diminished (Lambert & Kinsley, 1993).
Activity-based Anorexia (ABA) Variations
Prior exposure to deprivation stress or novelty stress has been found to affect the
results of the activity-based anorexia paradigm. However, questions remain as to which
determinant, for example, variations in activity patterns, meal frequencies, or housing
conditions, play a more critical role. Routtenberg isolated the variables relating to ABA
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in an attempt to further study the paradoxical effect of the ABA paradigm. He defined
“deprivation stress” as the stress resulting from the introduction of food restriction and
“novelty stress” as the stress related to exposure to a new environment (running wheels).
It was concluded that deprivation stress was essential for the “starvation” effect and
novelty stress only reinforced these effects (Routtenberg, 1968).
Kanarek and Collier proposed that the introduction of activity might interact with
a satiety mechanism that causes the termination of eating and that the initiation of ABA is
caused by a failure to adapt to a restricted feeding schedule (Kanarek & Collier, 1979).
Since then, much research has been done to pre-expose and adapt the laboratory animals
to one of the two stress factors before administering the second stress factor. In one
study, researchers have found that pre-exposure to wheel running increases the rate at
which weight loss occurs when a diet restriction is later imposed (Boakes & Dwyer,
1997). In a different study, running alone dramatically reduced body weight to the extent
that the experiment was terminated before food restriction was introduced (Verna Rose
Burden, 1992).
Unlike pre-adaptation to running, researchers tested the effects of pre-adaptation
to the restricted feeding schedule and determined the minimum feeding period required
for severe weight loss and ulcer development. The rats were divided into twelve
treatment groups. Six groups were pre-adapted to either a 1-hour or a 2-hour feeding
schedule and the other six groups remained on ad libitum feeding. All animals were
further divided into groups receiving 9, 18, or 24 days of acclimation to the feeding
schedules. When access to running wheels was introduced, the pre-adapted animals
remained on the same feeding schedules while the freely fed animals received the same
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restriction as those of the pre-adapted group. Results showed that with exposure to the
wheels, pre-adapted rats ate more than the freely fed rats. In addition, the animals
allowed the longest acclimation period ate and weighed more than those allowed shorter
acclimation periods. The non-adapted animals had a larger decline in body weight when
allowed access to running wheels (Pare, Vincent, & Natelson, 1985).
Consistent with these findings other researchers also found that pre-adapted rats
lost less weight and ate more than the non-adapted rat, which led to the conclusion that
prior adaptation to the feeding schedule can reduce the severity of ABA outcomes (V. R.
Burden, White, Dean, & Martin, 1993; Dwyer & Boakes, 1997). Contrastingly, Lett and
co-workers found that pre-adaptation to diet restriction did not eliminate ABA in rats.
The experimental animals that were adapted to the feeding schedule still ate less, weighed
less, and ran more than those of the control group (Lett et al., 2001). Nevertheless,
researchers concluded that if the paradigm was not as stringent as the typical ABA
procedure (i.e., feeding period of up to 2.5 hours during adaptation period and allowing
only 2 hours of wheel access prior to feeding rather than 90 min meal period and 22.5 hr
of access to wheel-running), rats who are pre-adapted to the restricted feeding schedule
show faster recovery than those who are non-adapted (Boakes & Dwyer, 1997).
The duration of the meal period also appears to take part in attaining anorexia.
For example, experimental rats were fed for 30, 45, or 60 minutes per day and were
restricted from activity one hour before feeding time. The control rats were restricted on
the same feeding schedule as described earlier but did not have access to activity wheels.
The results showed that all the animals in the experimental groups “starved” (starvation
criterion was defined as easing less than 1 gram during the feeding period) except for one
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rat from the 60-minute group, and all the animals in the 30-minute control groups
“starved” compared to one animal in the 60-minute control group (Routtenberg &
Kuznesof, 1967). Comparably, researchers found that ABA was more likely to be found
when the rats were fed 60 minutes per day rather than 120 minutes per day, and it was
more likely to occur when the rats were given a single feeding rather than multiple
feedings (Kanarek & Collier, 1979; Pare et al., 1985). For example, when there was a
variation in the frequency of the meals throughout the day, i.e., four 15-min, two 30-min
and one 60-min meal, animals fed the one 60-min meal demonstrated anorexia
characteristics as opposed to those fed four 15-min meals. It was suggested that ABA
resulted from the failure to overcome satiety signals rather than solely from an activityinduced food intake suppression (Kanarek & Collier, 1983).
It has long been determined that rats are nocturnal eaters and there are two peak
eating periods—one at the onset of the dark cycle and the other at the end of the dark
cycle (Dwyer & Boakes, 1997; Kersten, Strubbe, & Spiteri, 1980). Thus, to raise the
intricacy of adapting to the restricted feeding schedule, most experiments schedule the
feeding times during the light cycle. In an attempt to further study this phenomenon,
researchers tested whether the time of day of feeding has an effect on adaptation to a
restricted feeding schedule. The results showed that animals adapted to the feeding
schedule faster when fed during the dark cycle than when fed during the light cycle
(Dwyer & Boakes, 1997). Furthermore, Burden and lab, which wanted to control for
circadian rhythms in order to measure metabolites in the hypothalamic-pituitary-adrenal
axis, demonstrated that animals fed during the dark cycle could still reach the state of
activity-based anorexia (Verna Rose Burden, 1992).
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It is suggested that variable access to running wheels may have an effect on the
typical ABA outcome. For example, Epling and Pierce allowed varying amounts of time
of wheel access (2, 6, 12, 18, or 22 hours per day) for the experimental rats that were
restricted to a daily 90-minute feeding schedule. They found that rats that had more than
12 hours of access to running wheels indicated evidence of severe ABA (Epling &
Pierce, 1984). In another example, rats were allowed 30 minutes of feeding time per day
and restricted from activity for either up to 2 hours before or up to 2 hours after feeding
period. All of the experimental animals died within a mean number of 13.5 days. In a
further experiment, these researchers allowed the rats a 60-minute feeding period in
which wheel running was restricted for up to 3 hours before the meal. The results
showed that three out of five rats starved (Routtenberg & Kuznesof, 1967).
Likewise, Dwyer and Boakes found that ABA was indicated in rats that were
allowed activity for 4 hours prior to the feeding period rather than those allowed activity
for 18.5 hours after the feeding period. The rats demonstrated corresponding running
intensity except those who were allowed the 4-hour running time before the eating period
reduced their food intake. Therefore, it may seem essential to allow activity before
feeding to obtain the ABA effect (Dwyer & Boakes, 1997). Epling and Pierce suggested
that running alone could cause a decrease in food intake and body weight, regardless of
diet restriction. They concluded that a severe reduction in food intake would only occur
if activity “exponentially” increases; however, if activity remains stable or slightly
increases, the amount of food consumed will eventually counterbalance the amount of
energy expended (Epling & Pierce, 1988). As mentioned previously, a study by Burden
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demonstrated significant weight loss from running such that the experiment ended before
the introduction to food restriction (Verna Rose Burden, 1992).
Housing conditions can also influence the outcomes of the ABA paradigm. The
effects of isolation and communal housing on self-starvation were studied. Rats were
restricted to 60 minutes of feeding and allowed 22.5 hours of activity before the meal
period. Half the animals in the communally housed groups “self-starved” (eating <1
gram of food per day), but none of those in isolation did (Spatz & Jones, 1971). Animals
moved from individual housing to paired-housing showed a decrease in food intake as
well (O'Connor & Eikelboom, 2000). Conversely, other researchers found that
individually housed animals are slower to adapt to the feeding schedule than the animals
in the group-housing condition. Additionally, rats that were previously housed
communally and subsequently placed in isolation showed a higher decrease in body
weight and a slower recovery rate than those that remained communally-housed (Boakes
& Dwyer, 1997; Boakes et al., 1999).
Pathology
As mentioned earlier, activity-based anorexia can result in gastric ulcers. In this
situation, the procedure is referred to as the activity-stress (AS) ulcer paradigm
(Manning, Wall, Montgomery, Simmons, & Sessions, 1978; Pare & Houser, 1973). The
AS paradigm involves restricting meal times to 30-60 minutes per day and allowing
access to running wheels for the remainder of the day (Pare, 1975). Similar to ABA, the
animals will display high levels of activity and reduced food intake; however, they also
develop glandular lesions that penetrate the muscularis mucosa of the gastric lining.
More than half the animals constrained to this procedure die within 3-12 days. Thus, this
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paradigm has been suggested as a model for peptic ulcers in humans (Lambert, 1993;
Manning et al., 1978). Researchers studied the incidence of ulcerogenesis via other
methods such as using shock (Murison & Olafsen, 1991) or restraint techniques (Brodie
& Hanson, 1960; Politch & Herrenkohl, 1984); however, as acknowledged by Lambert,
using diet restriction and allowing access to voluntary activity is the most realistic
method if the results are to be compared with humans (Lambert, 1993).
In a study previously mentioned, rats given a shorter acclimation period with
access to food ad libitum produced the most ulcers when exposed to running wheels and
a 1-hour restricted-feeding schedule compared to those allowed pre-adaptation to the 2hour restricted-feeding schedule (Pare et al., 1985). Consistent with these results, a group
of rats pre-adapted to a 1-hour feeding schedule ran faster than the group of rats deprived
of the pre-adaptation period, yet the rats in the former group did not develop ulcers, while
signs of ulcerations were seen in the latter group (Morrow & Garrick, 1993). Tsuda and
co-authors suggested that gastric disease would not occur if rats were given food ad
libitum while exposed to the running wheels. The incidence of gastric disease or
ulcerogenesis would also diminish if rats were given access to running wheels with two
30-minute feeding sessions rather than one 60-minute feeding session. (Tsuda, Tanaka,
Iimori, Ida, & Nagasaki, 1981).
In a study referenced earlier, when male and female rats were castrated and
exposed to the AS paradigm, there was a significant difference in ulceration, with the
castrated male rats having 5.9% of the corpus ulcerated compared to 3.4% ulceration in
the castrated female rats (Lambert & Kinsley, 1993). In other studies that examined the
effects of gender, significant differences in weight loss between male and female rats
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were found, although researchers did not find any sex differences in ulcer sensitivity
when the animals were exposed to the AS paradigm (Doerries et al., 1991; Pare et al.,
1978).
Other tissues are also affected by a severe diet restriction and intensive exercise,
including the thymus, spleen, and adrenal glands. Hara and lab examined these organs as
well as the lungs and stomachs after the experimental rats were exposed to either a 60minute daytime feeding schedule or to a 60-minute nighttime feeding schedule in
combination with access to running wheels throughout the experiment. Rats that were
restricted to 60 minutes of feeding per day with no access to running wheels, and rats that
had access to activity wheels while on ad libitum feeding, revealed no signs of stomach
ulcers. However, there were signs of ulcers for those rats that were restricted to food
(night and daytime meals) and allowed access to running wheels. Whereas the rats that
were fed during the nighttime had a higher occurrence of ulcers compared to those who
were fed during the daytime, the latter group died earlier (day 6) than the former group
(day 10). In addition, the thymus and spleen weights of the two groups were lower than
normal, and the adrenal weights increased above normal. The organ weights of the rats
that were on a food-restricted diet with no access to activity wheels also changed
considerably, although the changes were only minor compared to the rats that were foodrestricted and allowed access to activity. There were reports of bleeding and
inflammation of the thymuses as well as bleeding and congestion of the lungs for most of
the experimental animals (Hara, Manabe, & Ogawa, 1981).
In another experiment, the incidence of gastric ulcers and the changes in thymus
and adrenal glands in male rats were examined. Experimental subjects were assigned to
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either an isolation- or group-reared condition (i.e., reared at 24-60 days old) and were
introduced to one 90-minute feeding period per day with 22.5 hours of access to wheel
activity. Results showed a higher incidence of a 25% weight loss (57% versus 18%) in
rats of the isolation-reared group. There was an indication of slight atrophy of the
thymus glands in the rats of the group-reared group. However, researchers did not find
any indication of gastric ulcers or any differences in the adrenal weights between the two
groups (Ness et al., 1995).
Hormones
Another component to take into consideration is the regulation of hormonal
secretion from endocrine glands as it is related to diet and stress. It has been well
indicated that stress, whether mental, physical, or any stimulant of the pituitary-adrenal
axis, induces the secretion of corticotropin-releasing hormone (CRH). Increased levels of
CRH stimulate adrenocorticotrophic hormone (ACTH) release from the anterior pituitary
glands, and elevated levels of ACTH ultimately stimulate the adrenal cortex for the
production of cortisol or corticosterone, all of which are regulated via negative feedback
inhibition. However, in patients with anorexia nervosa, there is an increase in CRH and
cortisol, however, the stimulation of ACTH from CRH is blunted because researchers
found either normal levels or lower levels of ACTH in AN patients (Licinio, Wong, &
Gold, 1996).
Cortisol counteracts the roles of insulin by inhibiting the activation of glycogen
synthase and the inhibition of glucose production and lipolysis (J. E. Hall & Adair, 1998).
Past studies have shown that if cortisol levels are elevated food intake should be
suppressed (Licinio et al., 1996; Rivier & Plotsky, 1986). For example, the effects of
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activity on food consumption in rats injected with either saline or alpha-helical
corticotropin-releasing factor (CRF), which is a CRF antagonist, in the right lateral
ventricle of the brain were studied. Researchers found that increases in CRF levels were
proportional to the risk of anorexia; that is, animals injected with saline and exposed to
forced physical activity (i.e., 40min motor-driven treadmill) demonstrated slower growth
and reduced food intake compared to those injected with saline without exposure to
forced activity. However, treatment with the CRF-antagonist prevented this anorexic
effect probably by hindering the decrease in food consumption and bodyweight in
exercising animals (Rivest & Richard, 1990).
In addition, researchers have shown that underweight anorexic patients display
elevated levels of CRH in the cerebrospinal fluid (CSF), which is then normalized after
weight restoration (Kaye et al., 1987). Similarly, anorexic patients show low responses
to elevated plasma cortisol levels, yet demonstrated normalization of levels and responses
after weight recovery. In healthy individuals, high levels of cortisol signal negative
feedback inhibition to decrease cortisol production and an increase in cortisol metabolism
in order to normalize plasma levels. Because the response (i.e., increased cortisol
metabolism and decreased cortisol production) is not high in anorexic patients, the result
is sustained hypercortisolism (Hotta et al., 1986). Boyar and lab first reported that the
hypercortisolism was an outcome of decreased cortisol metabolism (Boyar et al., 1977).
Another study suggested that low weight and hyperactivity, which is normally
seen in patients with anorexia, is not the primary causal factors in abnormal
neuropeptides (e.g., cholecystokinin [CCK], CRH, neuropeptide Y [NPY], galanin
[GAL], proopiomelanocortin [POMC]), rather food restriction is the principal contributor
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(Wong, Licinio, Gold, & Glowa, 1993). In this study, researchers measured the gene
expression levels for CCK, CRH, and POMC, which decrease food intake and NPY and
GAL, which increase food intake. These neuropeptides are involved in the regulation of
appetite and were measured in the paraventricular (PVN) and arcuate (ARC) areas of the
brain (animals were killed 30 min after meal period). Plasma measurements of ACTH
and corticosterone were measured as well. Food intake and bodyweight were also
measured daily. They found that although there were no significant differences in final
food intake (experimental animals ate 9% less than their controls) and final body weight,
there was a significant increase in ACTH and corticosterone in the experimental animals
when compared to the controls. There were no significant effects on the gene expression
levels of CCK, CRH, NPY, GAL, and POMC. Because food intake and body weight
were not significantly different, it was suggested that activity did not have an effect on
these neuropeptides even though it was associated with elevated levels of ACTH and
corticosterone (Wong et al., 1993). Thus, whether the increase in CRH/CRF (i.e.,
cortisol) level is the causal or the resulting factor or whether reduced food intake,
decreased bodyweight, or hyperactivity, is the primary or secondary factor, it is well
supported in several past experiments that there is a strong association between the
elevation in cortisol levels and anorexia (Hotta et al., 1986; Kaye et al., 1987; Licinio et
al., 1996; Rivest & Richard, 1990; Wong et al., 1993).
Serotonin, also known as 5-hydroxytryptamine (5-HT), is another hormone that
plays a role in feeding behavior. Its receptors are widely found in the hypothalamus and
in the gut, thus, alterations to the hypothalamus (e.g., lesions or drug injections) or
modifications of the gastrointestinal tract (e.g., increases in intraluminal pressure or pH in
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duodenum) can cause changes in eating behavior. Serotonin has a specific effect on
satiety rather than hunger signals (Blundell, 1977), thus, increases in serotonin levels are
expected to decrease food consumption. Scientists have developed anorectic drugs (e.g.,
fenfluramine and fluoxetine), which act on serotoninergic mechanisms to inhibit food
intake, for the treatment of obesity (Carruba et al., 1986; Fessler, 2002; Rieg et al., 1994).
However, the effects of elevated serotonin (5-HT) on food intake have shown conflicting
results in one study. For example, researchers found that increases in serotonin levels did
result in a reduction in food intake (Carruba et al., 1986). However, others have shown
that low levels of serotonin levels were associated with a decreased food intake and that
elevated serotonin levels resulted in a reduction in weight loss (Altemus, Glowa,
Galliven, Leong, & Murphy, 1996). In the former study, researchers demonstrated that
subcutaneous injections of serotonin were strong enough to suppress food intake in
hyperphagic-induced rats injected with insulin or 2-deoxy-D-glucose (2-DG). In the
latter study, researchers tested the effects of two drug treatments in rats: fluoxetine,
which improves serotonin activity, and parachlorophenylalanine (PCPA), which is a
tryptophan hydroxylase inhibitor. They found that rats treated with fluoxetine via
intraperitoneal (IP) injections significantly lost less weight, showed less activity, and
increased food consumption compared to saline-treated animals. Animals treated with
PCPA via IP injections demonstrated opposite results from fluoxetine-treated animals
when compared to saline-treated animals (i.e., significantly lost more weight, showed
more activity, and reduced food consumption). Nevertheless, more evidence indicates
that serotonin levels are inversely related to food intake and that anorexic individuals
display lower than normal levels of 5-hydroxyindole acetic acid (5-HIAA), a serotonin
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metabolite that has been found to be at above normal levels when patients have restored
body weight (Rieg et al., 1994).
Catecholamines (epinephrine [E], norepinephrine [NE], and dopamine [DA])
function in the promotion and regulation of energy metabolism. E and NE are secreted
by adrenal medulla in a 4:1 ratio, respectively. The functions of E and NE include
stimulation of adrenergic system, increase efficiency of muscular contraction, increase
rate of glycogen breakdown into glucose, & increase rate of fatty acids (FA) release from
fat. Also, E (not NE) increases release of ACTH. Because cortisol exerts permissive
effects on the actions of catecholamines (E and NE), the catecholamines are not as
effective as they are normally when cortisol levels are low (J. E. Hall & Adair, 1998).
Exercise tends to increase plasma NE concentrations (Duncan et al., 1985; Kohno
et al., 2000). Additionally, DA plays a role in maintaining high levels of physical activity
and suppressing food intake; thus contributing to the anorexic effects caused by the
activity-stress model (Avraham, Hao, Mendelson, & Berry, 2001; Carruba et al., 1986;
Lambert & Porter, 1992; Lyons & Truswell, 1988). Researchers studied the effects of
pimozide, a dopamine-D2-receptor blocker, in rats exposed to the activity-stress model
and found that although it did not affect activity levels in the dark phase, it significantly
reduced wheel running in the light phase resulting in an increase in number of surviving
animals (Lambert & Porter, 1992).
Diet and Metabolism
Few studies have manipulated the diet in an attempt to attenuate the negative
effects of deprivation and novelty stress in the activity-based anorexia paradigm. For
example, the effects of pellet-form and powder-form of food on body weight, food intake,
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and level of activity were examined in one study. Neither form of food eliminated
starvation in rats; however, diet restriction and activity continued to affect the ABA
outcomes. Wheel access did not affect weight gain in those rats that had food available
ad libitum, though, it did result in starvation of more than 75% of rats who were restricted
of food and allowed access to wheels (Beneke et al., 1995).
Researchers have studied the nutritional status of the individual or subject and the
nutritional content of the diet as well. Scientists have shown that tyrosine injections can
prevent the activity-induced elevation of 5-HT levels in the hypothalamus thereby
improving food consumption in rats exposed to the activity anorexia model. The rats to
be injected with tyrosine initially lost weight and decreased food intake when introduced
to the activity anorexia model; however, despite the sustained increase in activity, food
intake was returned to normal when compared to that of the saline-injected controls when
tyrosine injections were administered (Avraham et al., 2001). In addition, Davis and
associates have suggested that carbohydrates (CHO) and branch-chained amino acids
(BCAA) might prevent the activity-induced increase in 5-HT concentrations. These
researchers found that during prolonged exercises, fatigue was associated with elevated
concentrations of 5-HT and a high ratio between 5-HT and dopamine levels; thus,
lowering levels of 5-HT may decrease fatigue and sustain high energy levels (J. M.
Davis, Alderson, & Welsh, 2000). Furthermore, others have suggested that a high CHO
meal should have greater effects on serotoninergic effects when compared to a low CHO
meal since CHO have been shown to increase plasma tryptophan (Lyons & Truswell,
1988).
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In another experiment, researchers fed animals either a commercial lab diet
containing 4.5% fat and 51% carbohydrates or an experimental diet that is high in fat
(nearly 26% fat and no carbohydrates). The rats that were fed the commercial diet ran
five times more when restricted of food, and lost roughly 29% of their initial body
weight, compared to the rats that were fed the high fat diet—the rats on the high fat diet
increased their running at a much slower pace than those fed the commercial diet. Ninety
percent of the animals fed the high fat diet survived in contrast to only 20% of the rats fed
the commercial diet. It was suggested that the energy density of the high fat diet might
help animals maintain a more normal body weight when exposed to the ABA model
(Barboriak & Wilson, 1972). A past study by Roy and lab demonstrated that rats fed a
low-energy density diet increased food intake to increase energy consumption (H. J. Roy
et al., 2003). However, as mentioned above, the contents of the meal should not be the
only factor to consider in ABA.
The effect of carbohydrate metabolism on blood glucose levels (BGL) has been
extensively studied especially in the study of hyperinsulinemia and insulin resistance.
The transient hyper- and hypo-glycemic phase, which normally occurs hours after
ingestion of a moderate to high carbohydrate meal, has been shown to signal many
metabolic mechanisms (i.e., anabolism and catabolism of energy stores) that are assumed
to play an important role in ABA (Ettinger, 2000; Winkler & Manchester, 2000). Insulin
and glucagon, both of which are secreted by the pancreas, are the two primary hormones
functioning antagonistically to maintain euglycemia. Insulin, which is released in
response to high BGL, serves to lower BGL by promoting glucose uptake in cells,
formation of fat (lipogenesis) and formation of glycogen (glycogenesis). Glucagon,
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which is released in response to low BGL or raised epinephrine levels, functions
synergistically with epinephrine to raise BGL by stimulating the hydrolysis of stored
glycogen (glycogenolysis) and fat (lipolysis) (J. E. Hall & Adair, 1998).
Because impaired glucose tolerance (IGT) is frequently found in anorexic human
individuals (Sheldon & Young, 1938; Silverman, 1977), the effects of plasma glucagon,
glucose and insulin levels before and after dietary therapy and glucose challenges were
studied. Before treatment, researchers found that circulating plasma glucagon levels and
plasma glucose levels were higher in AN subjects compared to the controls after the
glucose meal; however, levels were suppressed after therapy. Conversely, plasma insulin
levels were lower in AN than those of the controls before and after the glucose meal and
remained the same after the treatment. It was concluded that IGT found in AN patients is
possibly due to abnormalities in the secretion of insulin and glucagon from the pancreas,
which does not completely regularize after diet therapy (Kumai, Tamai, Fujii, Nakagawa,
& Aoki, 1988).
Studies have shown that insulin-induced hypoglycemia, as well as 2-deoxy-Dglucose, can raise feelings of hunger in humans (Silverstone & Besser, 1971; Thompson
& Campbell, 1977). 2-deoxy-D-glucose (2-DG) is a glucose anti-metabolite or analogue
that functions to inhibit glucose uptake and metabolism. 2-DG is known to induce
hyperphagia in normal individuals (Frohman & Nagai, 1976); however, it has been
shown to decrease hunger in anorexic human patients when compared to controls
(Aravich, Stanley, & Doerries, 1995). A study with humans suggested that the
paradoxical response to 2-DG is not limited to those with anorexia nervosa. The doubleblind study included six participants with anorexia (ranging from 51.4 to 68.4% IBW),
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three participants with bulimia (106.3%, 100%, and 51.4% IBW), and six controls
participants (ranging from 85.3% to 104.2% IBW). The participants were infused with
50mg of either 2-DG in saline or saline alone over 20 minutes. For a total of three hours,
participants evaluated their hunger and thirst ratings on a line scale 30 minutes before
infusion and every 30 minutes after infusion. Blood, blood pressure, pulse rate, and oral
temperature were taken at those times as well. Approximately 2.5 hours after the start of
infusion, the participants were given a 20-minute lunch and a questionnaire to evaluate
their judgment of satiety. In the end, all the anorexic participants showed a decrease in
hunger ratings after the 2-DG infusion. Only the emaciated bulimic participant (51.4%
IBW) showed the paradoxical effect of 2-DG while those of normal weight increased
their hunger ratings (Nakai, Kinoshita, Koh, Tsujii, & Tsukada, 1987).
Consistent with the results reported for humans, in an animal study, rats were
matched by weight and assigned to one of three experimental groups (deprived of food
only, allowed access to wheels only, or exposed to both conditions) or the control group.
When the animals lost 25% or more of their initial weight, they were randomly assigned
to receive either a 2-DG or saline injection within two hours before the 6-hour feeding
period and then decapitated. The 2-DG injection caused significant reductions in food
intake in both the ABA animals and the animals that lost weight due to food deprivation.
It was proposed that 2-DG has a paradoxical effect for underweight individuals and does
not affect those at a normal or above-normal body weight (Aravich et al., 1995).
Furthermore, the effects of ABA on plasma glucose and insulin levels in animals
administered 2-DG injections were examined. The protocol was similar to the one
described above, except that all the groups received 2-DG injections. Results show that
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weight changes were comparable to the previous experiment. In addition, plasma glucose
and insulin levels were reduced in ABA subjects and subjects deprived of food when
injected with 2-DG before a meal. Researchers concluded that the abnormal effects of 2DG on appetite, plasma glucose and plasma insulin levels, which all contribute to weight
loss, that occur in this model are strongly comparable to anorexia nervosa in humans
(Aravich et al., 1995). Consistent with these results, Pare demonstrated that AS rats had
a significant reduction in liver glycogen and serum glucose; therefore, they proposed that
these results were due to “exhaustion of metabolic substrates (p.419)” (Pare, 1980).
The theory of the glycemic index (GI) of foods first gained popularity in 1981
(Berning, 2000; Brand-Miller, Nantel, Suma, & Lang, 2001). GI represents the ratio of
the area under the curve (AUC) of the blood glucose response curve over the first two
hours of ingesting of a given quantity of the test CHO and AUC of the blood glucose
response over the first two hours of consuming the same quantity of CHO from a
standard food (e.g., white bread or glucose) (Vonk et al., 2000). This ratio, or GI score,
indicates the potential of the CHO to raise blood glucose levels after ingestion of that
particular CHO. Foods with a high GI have been shown to have a higher overall blood
glucose response during the first 2 hours after meal consumption and an elevated
secretion of insulin compared to foods with a low GI.
About two decades ago, a diet/meal with a low glycemic index was found to be
beneficial because it produces only a minimal rise in post-prandial glucose and insulin
levels. A high-GI diet/meal would have otherwise produced varying fluctuations in
blood glucose and insulin levels and eventually low BGL in the late post-prandial period
(Brand-Miller et al., 2001; Crapo, Insel, Sperling, & Kolterman, 1981; Febbraio, Keenan,
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Angus, Campbell, & Garnham, 2000; Jenkins et al., 1987). Low GI foods take longer to
digest and absorb, thus, suppressing hepatic glucose and fatty acid production (Liljeberg,
Akerberg, & Bjorck, 1999).
In one study, healthy male human volunteers were assigned to an individualized
low-GI diet (test 1) and a high-GI diet (test 2) for two 2-week testing periods. The lowGI diet consisted of 26g of fiber per 1000 kcal with a GI score of 64. The high-GI diet
contained 21g of fiber per 1000 kcal and had a GI score of 104. Results showed that
there was a 37% smaller rise in post-prandial BGL over 12 hours for the men on the lowGI diet compared to the men on the high-GI diet. In addition, insulin secretion, which
was calculated from 24-hour urinary C-peptide measurements, was 32% lower in the
low-GI diet. At the end of the high-GI and low-GI periods, results from another standard
test meal demonstrated higher blood glucose levels 45-minutes following the low-GI diet,
although C-peptide levels remained low. It was concluded that a low-GI diet has a
positive effect on insulin secretions, and therefore CHO and lipid metabolism, in healthy
male humans (Jenkins et al., 1987). Likewise, in another study, a high GI meal produced
higher post-prandial BGL, however, it also created lower BGL at the onset of exercise
compared to a low GI meal despite no differences in exercise performance (Febbraio et
al., 2000). Conversely, other studies have shown a different effect (Brand-Miller et al.,
2001; Kirwan, Cyr-Campbell, Campbell, Scheiber, & Evans, 2001; Thomas,
Brotherhood, & Brand, 1991). In these trials, the low GI theory (i.e., the slow release of
glucose into blood) has been shown to enhance physical performance, for example, by
increasing exercise endurance if the meal was consumed 45 minutes to1 hour rather than
3 hours prior to exercise (Brand-Miller et al., 2001). Perhaps the difference between the
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two studies is the method of measurement—the former study measured exercise
performance within 120 minutes while the latter studies measured performance via a
fatiguing concept (i.e., participants are evaluated based on the amount of time it takes to
reach exhaustion).
Recently, resistant starch (RS) has gained attention for possessing characteristics
that are similar to dietary fiber, especially to that of soluble fiber. It has been reported to
produce BGL responses similar to that of low GI foods (Jenkins et al., 1987; Ring, Gee,
Whittam, Orford, & Johnson, 1988). RS, which is found at low amounts in many foods,
is the form of starch that escapes the small intestine and is primarily fermented in the
large intestine, which results in decreased post-prandial glucose and insulin response. RS
can be defined as “the sum of starch and products of starch hydrolysis not absorbed in the
small intestine of healthy individuals (p. 23)” [from (Muir, Young, & O'Dea, 1994):
European Concerted Action of Resistant Starch (EURESTA), June 1990]. RS has been
categorized into four types: RS1, RS2, RS3, and RS4; however, most interest has been
directed to RS2 and RS3 (Muir et al., 1994). RS2 is the ungelatinized starch granule,
which is unavailable to digestible enzymes (e.g., amylase) due to its compact, unhydrated
structure. This type of RS can be found in cereals, legumes, raw potatoes, unripe
bananas, or high amylose maize starch and is most commonly used in research. RS3
consists highly of crystalline amylose and amylopectin, which forms during starch
retrogradation or recrystallizaton. This type of RS can be found in bread or cooled boiled
potatoes since it forms after the heating and later cooling of the food product (Haralampu,
2000; Muir et al., 1994).
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In an experiment that examined the digestion of resistant starch in the small
intestine, researchers studied the metabolism of highly digestible cornstarch (DSC),
Hylon VII (RS2) and Novelose 330 (RS3). Twenty-one healthy human volunteers
consumed 40g of glucose and one of the three starches after fasting for 10 hours.
Measurements of plasma exogenous glucose concentrations and breath excretion of
13

CO2 are indirect indications of intestinal digestion. Analysis revealed the highest

response in breath hydrogen and exogenous glucose response levels after the DCS meal,
primarily because of its high digestibility. Average GI scores, which were determined
after the intake of 40 grams of starch, were 98+138, 22+13, and 48+28 for DCS, Hylon
VII and Novelose 330, respectively. DCS was estimated to be 80% digestible in contrast
to an approximate 50% digestibility of the resistant starches, with no differences between
the two types (Vonk et al., 2000).
Because resistant starch is fermented in the large intestine, the production of
short-chained fatty acids (SCFA) (e.g., butyric, acetic, and propionic acids) may
contribute to “total metabolizable energy” (Behall & Howe, 1996; Cummings & Englyst,
1987; Ferguson, Tasman-Jones, Englyst, & Harris, 2000). Twenty-four volunteers (ten
controls and fourteen hyperinsulinemic participants) were fed individualized diets with
the primary carbohydrate as either high amylose cornstarch (AM: containing 70%
amylose, 30% amylopectin) or a standard cornstarch (AP: containing 30% amylose, 70%
amylopectin) for fourteen weeks. Although results showed that the consumption of the
AM diet resulted in increased fecal output and nitrogen, there were no differences in
metabolizable energy between the two diets. The results indicated that utilization of RS
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provided energy for both the control participants (81.8% utilization) and for the
hyperinsulinemic participants (53.2% utilization) (Behall & Howe, 1996).
There are implications that resistant starch may have a positive effect for
overweight, diabetic, hyperlipidemic, or cancerous individuals (Raben, Tagliabue et al.,
1994); (Muir et al., 1994). Evidence have supported the idea that RS can help regulate
the release of anabolic and catabolic hormones by producing minimal fluctuations in the
blood glucose level after a meal (Byrnes, Miller, & Denyer, 1995; Hallfrisch & Behall,
2000). The slow absorption of RS in the small intestines of humans caused reductions in
post-prandial glucose and insulin levels (Muir et al., 1994). The effect on post-prandial
plasma concentrations of glucose, lipids, and hormones in normal-weight, young males
were studied. Participants were assigned either to a diet containing 54.1% RS (R-meal) or
to one that is 100% digestible (S-meal) for two test periods. Results showed that plasma
glucose, lactate, insulin, GIP, and GLP-1 levels increased markedly after consumption of
the S-meal compared to R-meal. Plasma triglycerides decreased after both S-meals and
R-meals. Plasma glycerol also decreased after the S-meal, but remained reasonably
constant after the R-meal. Significant differences were not found in norepinephrine
levels after both meals, but epinephrine levels increased after the S-meal (Raben,
Tagliabue et al., 1994).
Summary
In summary, in can be concluded that:
1. Excessive exercising, diet restriction, and low body weight is strongly associated
with anorexia.
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2. The results of the activity-based anorexia model mimic the characteristics of
individuals with anorexia nervosa.
3. Animals exposed to the ABA procedure typically display reduced food intake and
body weight, increased activity, elevation of corticosterone levels, hypertrophy of
the adrenal glands, and atrophy of the thymus glands.
4. Young animals weighing less than 250g (on average) are more prone to the ABA
paradigm; however, it is controversial whether which gender is more vulnerable
to the ABA model.
5. Pre-adaptations to the feeding schedule or activity schedule, changes in the
feeding duration, frequency, and time of day, and variations in the access to the
running wheels can affect the ABA outcomes.
6. Elevated levels of CRH, ACTH, corticosterone, epinephrine, norepinephrine,
and/or dopamine may be associated with anorexia or cachexia.
7. A high-fat diet provides protection for animals exposed to the ABA model
compared to a normal commercial diet.
8. Incorporation of resistant starch in the diet can result in significant reductions in
post-prandial glycemia and insulinemia, therefore suppressing hepatic glucose
and fatty acid production and conserving energy stores (i.e., glycogen and fat) in
the body.
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CHAPTER 3
MATERIALS AND METHODS
The activity-based anorexia (ABA) animal model has clinical significance
because many individuals with anorexia nervosa often use intense exercising and severe
diet restriction as a means of losing weight and maintaining the weight loss (Kron et al.,
1978). To our knowledge, only a few experiments have directly examined the effects of
diet composition on activity-based anorexia. Therefore, the proposed study was
conducted in two experiments. Experiment one was done to replicate the standard ABA
procedure using a control diet (see Table 1). Experiment two included resistant starch
(RS2 ), which has a lower glycemic index, in the experimental diets (see Table 1) during
exposure to the activity-based anorexia paradigm. Resistant starches, which have
recently gained interest for its similarity to dietary fiber, are glucose polymers that resist
digestion by enzymes in the small intestines; consequently, the products of hydrolyzed
starch are not readily absorbed in the small intestine. Muir and associates demonstrated
that the slow absorption of RS in the sma ll intestines of humans caused reductions in
post-prandial glucose and insulin (Muir et al., 1994). Therefore, with the diet
manipulation, it is predicted that the resistant starch diet will cause minimal rises in the
blood glucose levels, thus, a slower, controlled release of anabolic and catabolic
hormones (Byrnes et al., 1995; Hallfrisch & Behall, 2000; Raben, Tagliabue et al., 1994),
and ultimately preserving the body’s energy stores and reducing weight loss.
General Materials and Procedures
Animals. Sprague-Dawley male rats were purchased from Harlan Bioproducts
for Science, Inc. (Indianapolis, IN). They were maintained on a 12-hour light/dark cycle
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Table 1. Diet Composition1 : Percent of Diet and Caloric Breakdown
Ingredients

Experiment 1
Control Diet

Experiment 2
Control Diet
Resistant Starch
Diet
2
3
Percent
Kcal
Percent 2 Kcal3
53.1
1.91
19.7
0.71

Percent 2
46.0

Kcal3
1.65

--

--

--

--

33.3

0.52

20.0

0.72

20.0

0.72

20.0

0.72

Sucrose6

10.0

0.40

10.0

0.40

10.0

0.40

Cellulose6

5.0

0.00

5.0

0.00

5.0

0.00

Mineral Mix
(AIN-93G) 1,6
Vitamin Mix
(AIN-93G) 1,6
Choline
Bitartrate6
Choline
Chloride6
L-Cystine6

3.5

0.03

3.5

0.03

3.5

0.03

1.0

0.04

1.0

0.04

1.0

0.04

0.3

0.00

--

--

--

--

--

--

0.1

0.00

0.1

0.00

0.3

0.01

0.3

0.01

0.3

0.01

Soybean Oil7

14.0

1.26

7.0

0.63

7.0

0.63

BHT6, 8

0.001

Amylopectin
Cornstarch4
High
amylose
starch5
Casein6

Kcal/g Food

0.001
4.11

0.001
3.74

1

3.05

AIN-93G (Reeves, Nielsen, & Fahey, 1993)
All values are in percent of diet
3
All values are in kcal per g food
4
High Amylopectin starch (100% amylopectin), (Cerestar, Hammond, IN), (3.5kcal/g)
5
Hi-Maize (60% amylose, 40% amylopectin), (Renford, Plover, WI), (estimated as
1.65 kcal/g)
6
Sucrose was attained from Thrifty Maid (Sun Mateo, CA) and Casein, Cellulose,
Mineral Mix AIN-93G, Vitamin Mix AIN-93G, Choline Bitartrate, Choline Chloride,
L-Cystine, and BHT were attained from Dyets (Bethesda, PA), which also provided
energy values of diet ingredients.
7
Soybean oil (Aster) was attained from Deep South Products.
8
0.015% of Butylated Hydroxytoluene (BHT) was mixed in soybean oil
2
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in a temperature-controlled room (22-25 degrees Celsius) that was automatically
illuminated at 7AM-7PM. Water was available ad libitum throughout the experiment.
Unlimited access to powdered food was available to all the animals throughout the
acclimation period and to specified groups (see below) during the experimental period.
All diets were modified versions of the American Institute of Nutrition-93-Growing diet
(AIN-93G) (Reeves et al., 1993). The compositions of the diets are shown in Table 1.
The different diets and feeding schedules are described in further details below.
Apparatus. All the animals in experiment one were housed in Columbus
Instruments Mechanical Activity Monitor Wheels (Columbus, OH), which are made of
stainless steel and Plexiglas. The wheel, which has a mesh running surface and measures
14” in diameter and 4” in width, is connected to a mechanical counter that records the
number of complete wheel revolutions in either direction. Adjacent to the wheel, but
separated by a sliding door, is a 10”x 6”x 5” mesh wired-bottom cage for which the
animal has access to food and water. The sliding door was manually opened and closed
by the experimenter. A water bottle is mounted on the side of the cage with the
mouthpiece inserted through a mesh hole, and a food cup is secured within the cage by
wired springs. In experiment two, half the animals were housed in the Columbus
Instruments Mechanical Activity Monitor Wheels (as used in experiment one), and the
other half were housed in standard 8”x 10”x 7” hanging stainless steel cages with wired
bottoms. Those housed in the hanging steel cages received water via a watering system
and those housed in the mechanical wheels received water via water bottles (see below
for details on housing). All food cups are secured within the cages by wired springs in
both housing environments.
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General Procedures. Upon arrival in the laboratory, the animals were
acclimatized to the environment, and food and water were available ad libitum
throughout this period. A run-test, which is an assessment of spontaneous activity, was
administered in order to eliminate abnormally low- and high- level runners (details
below). Epling and Pierce selected the “most active” animals and assigned them to the
running groups (Epling & Pierce, 1984). However, to avoid unusually low or high
activity, assignment to running groups was determined by selecting half the animals with
the total number of wheel revolutions nearest to the mean number of total wheel
revolutions during the run-test. The chosen animals were stratified by the results from
the run-test and by their current weight and then randomly assigned into one of the
running groups. The remaining animals were stratified by their current weight and
randomized into one of the groups with no access to running wheels.
During the experimental period, the animals followed their specified feeding and
activity schedules (more details below). Wheel rotations for the individual running
animals were recorded daily and all the animals were weighed everyday. Throughout the
run-test and experimental periods, the animals were not restricted to the wheels in order
to avoid forcing activity upon the animals. Measurements for food intake were taken
immediately before and after the feeding period for animals on a restricted feeding
schedule by weighing the food cups and food spillage daily; however, measurements for
animals on an ad libitum feeding schedule were taken every other day. Food spilled from
the food cups of all animals were weighed and recorded. Food was replenished at least
every other day and water bottles were changed daily. The experiment ended when the
majority of the animals in the ABA group (i.e., animals subjected to restricted feeding
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and liberal activity) have met one of the two criteria. The animals were considered to
reach the anorexia criteria when the majority of the animals from the ABA group reached
75% or less of their pre-experimental body weight for 2-consecutive days. However, the
animals were considered to reach the recovery criteria when the majority of the animals
from the ABA group have stabilized their weight. That is, when the animal’s weight on
day 4 is at or above its weight on day 1 in any consecutive-4-day period. Due to the large
number of animals, the termination period took place on two consecutive days. On the
day of the kill, all animals chosen for decapitation are weighed at 4PM and tissue
collections began at 4:30PM. Tissues and fat pads were rapidly excised, examined, and
weighed. Livers were immediately frozen in liquid nitrogen and the brains were frozen
on dry ice. Trunk blood was collected and immediately placed on ice. All samples were
kept in –80°C until needed for analyses.
Experiment One (2x2 Factorial Design)
In this experiment, twenty-eight 4-week old male Sprague-Dawley rats were
maintained on a 12- hour light/dark cycle (automatically illuminated at 7AM-7PM). All
the animals were fed a 14% fat, high- GI (Control) diet throughout the experiment (see
Table 1). Upon arrival in the laboratory, the animals were assigned to wheel cages with
the passage to the wheels locked. The animals were acclimated for approximately one
week (day -8 to day –1), throughout which water and food were fed ad libitum and access
to activity wheels was not allowed. The acclimation period occurred in the same room as
the experimental period. During acclimation, all the animals were subjected to a run-test.
Because there were a limited number of wheels that were functioning properly, the runtest was divided into two days. Half the animals (n=14) were tested on day -6 at
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1:30PM-3:30PM (100% light) and the other half (n=14) were tested on day -5 at 1:00PM3:30PM (100% light). As described earlier, the animals were assigned to the running
groups by selecting half the animals with the total number of wheel revolutions nearest to
the mean number of total wheel revolutions during the run-test. The chosen animals were
stratified by the results from the run-test and by their current weight and then randomly
assigned into one of the running groups. The remaining animals were stratified by their
current weight and randomized into one of the groups with no access to running wheels.
The four groups consisted of two running groups (R/RF, R/AL) and two non-running
groups (NR/RF, NR/AL). One active group and one inactive group were fed ad libitum
(R/AL, NR/AL) while the other two groups were on a restricted feeding schedule (R/RF,
NR/RF; see Figure 1).

Ad lib

7 (NR/AL)

No Running
Restricted
28
rats

Ad lib

7 (NR/RF)
7 (R/AL)

Running
Restricted

7 (R/RF)

Figure 1. Experiment One (n=28)

At the start of the experimental period (day 0 at 6PM), the doors to the running
wheels were opened for the specified animals (R/RF, R/AL) allowing them access to the
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activity wheels and the food was removed from the appropriate animals (R/RF, NR/RF).
From day 1 onward (see Figure 2), the restricted- fed animals were allowed one 90- minute
meal period daily (4:30PM-6PM; 100% light cycle), which preceded the dark cycle, and
the running animals were allowed 22 hours of activity (6PM-4PM; 55% dark/45% light
cycle) immediately after the meal period. Total wheel revolutions were recorded daily at
exactly 4PM, and body weights were taken during the 30- minute transition time (4PM4:30PM), which occurred after physical activity but before the meal period. Food intake
measurements were taken at least every other day throughout the experiment.
The experimental period terminated when the majority of the animals from the
R/RF group reached the recovery criteria, that is, their weights on day 4 was at or above
their weights on day 1 in a consecutive 4-day period. Blood glucose levels were
measured at the time of decapitation; glucose levels were measured using the Advantage
Accucheck glucose meter from Roche Diagnostics (Indianapolis, IN). Trunk blood was
collected for measurements of plasma catecholamines, corticosterone, insulin, and
glucagon levels. Burden and co-authors showed an increase in corticosterone levels in
experimental animals; however, they found norepinephrine levels to be consistent among
all groups (V. R. Burden et al., 1993). Also, the insulin and glucose levels were
significantly lower in animals exposed to both running and food-restricted conditions
compared to the controls. Abdominal, perirenal, and epididymal fats, as well as brown
fats, were removed and weighed. A past study (V. R. Burden et al., 1993) demonstrated
that animals exposed to running wheels and restricted to one daily meal lost up to 52%
body fat compared to those only food-restricted. The thymus, livers, spleens, kidneys,
and adrenal glands were also removed, weighed, and examined for abnormalities.
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Figure 2. Daily Schedule for Animals (Experiment 1 & 2)
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Studies have found a decrease in thymus and spleen weights and an increase in adrenal
weights in ABA animals compared to the controls (V. R. Burden et al., 1993; Hara et al.,
1981). Stomachs were removed, weighed, and examined for ulcers. The protocol was
submitted to and approved by the Institutional Animal Care and Use Committee
(IACUC) of Louisiana State University A& M College in Baton Rouge, Louisiana
(Appendix A & B).
Experiment Two (2x2x2 Factorial Design)
The model used in this experiment followed the method as described above,
however, there were a few modifications. In this experiment, fifty-six 4-week old male
Sprague-Dawley rats were maintained on a 12-hour light/dark cycle (automatically
illuminated at 7AM-7PM). Upon arrival (day -7) to the facility, the animals were
randomized into the two different diet groups (see Table 1) and were fed the specified
diet throughout the acclimation period, which lasted one week (day –7 to day -1), and the
experimental period. All the animals were individually housed in standard hanging steel
cages (as described previously) in a quarantine room for the first 5 days of acclimation
(days -7 to –2) and were given water and food ad libitum. The animals were then
transferred to the experimental animal room on day -2, and all animals remained in the
standard cages until the start of the experiment (day 0) or unless otherwise stated below.
Both the quarantine and experimental rooms were temperature-controlled and
automatically illuminated at 7AM-7PM.
On the first day the rats were transferred to the experimental room (day -2), 28
rats (14 rats from the Control group and 14 rats from the RS group) were randomly
selected for the first run-test. Unlike experiment one, this test allowed the rats access to
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running wheels for 14 continuous hours, which consisted of 2 hours in the light cycle
(5PM-7PM) and 12 hours in the dark cycle (7PM-7AM). The rats were transferred to
wheel cages during the test and were returned to their standard cages when testing was
not in session. At 4:30PM, the rats were transferred to the wheel cages (with their
specified food and water) and the passages to the wheels were opened at 5:00PM. On the
following day (day-1), the passage doors to the wheels were closed at 7AM and the rats
were immediately returned to their previous cages. The same procedure followed for the
second half of the animals on this day (day -1).
As in experiment one, the animals were assigned to the running groups by
selecting half the animals with the total number of wheel revolutions nearest to the mean
number of total wheel revolutions during the run-test. The chosen animals were stratified
by the results from the run-test and by their current weight and then randomly assigned
into one of the running groups within the diet group. The remaining animals were
stratified by their current weight and randomized into one of the groups with no access to
running wheels within the diet group. Because the animals were acclimated on a
specified diet and needed to remain on the diet for the remainder of the experiment, they
were stratified and randomized within their own diet group. The eight groups in this
experiment consisted of four running groups (R/AL, R/RF, rsR/AL, rsR/RF) and four
non-running groups (NR/AL, NR/RF, rsNR/AL, rsNR/RF). Two active groups and two
inactive groups were fed ad libitum (NR/AL, R/AL, rsNR/AL, rsR/AL) while the
remaining four groups were on a restricted feeding schedule (NR/RF, R/RF, rsNR/RF,
rsR/RF). The animals were also fed one of two different diets. Four groups (NR/AL,
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NR/RF, R/AL, R/RF) were fed a high- GI diet containing regular cornstarch (7% fat,
Control) and the other four (rsNR/AL, rsNR/RF, rsR/AL, rsR/RF) were fed a low-GI diet
containing resistant starch (7% fat, RS) diet (see Table 1 and Figure 3). After the
assignment of groups, the animals were then transferred to their appropriate cages for the
experimental period.

Ad lib
No Running

Restricted

7 (NR/AL)
7 (NR/RF)

Control
Ad lib
Running Restricted

7 (R/AL)
7 (R/RF)

56
rats
Ad lib
No Running

Resistant
Starch

Restricted

Ad lib
Running Restricted

7 (rsNR/AL)
7 (rsNR/RF)

7 (rsR/AL)
7 (rsR/RF)

Figure 3. Experiment Two (n=56)

On the first day of the experiment (day 0), all animals were placed in either the
standard cages or wheel cages according to their assigned group at 4PM and the daily
routine for all 8 groups followed the same procedures as in experiment one. At exactly
6PM (beginning of experimental period), food was removed from tho se on the food-
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restricted feeding schedule (NR/RF, R/RF, rsNR/RF, rsR/RF), and passages to wheels
were allowed for those allowed physical activity (R/AL, R/RF, rsR/AL, rsR/RF). Food
was also replenished, weighed and given to those on an ad libitum diet schedule (NR/AL,
R/AL, rsNR/AL, rsR/AL) at this time.
The experiment terminated on day 5 when majority of the animals in rsR/RF
group reached the anorexia criteria, that is, they experienced 25% weight loss from preexperimental body weight. The termination period followed similar procedures as
experiment one, however, there were a few changes. One, stomachs were collected
without emptying and examining for irregularities; thus, we will eliminate stomach data
all together. Two, blood serum was collected for two animals that were killed earlier that
day (11AM) and blood plasma were collected for the other 53 animals killed later that
day and the following day, however, this will not affect certain humoral analysis. Three,
rather than using a glucose meter to measure blood glucose levels at time of death as in
experiment one, plasma and serum glucose levels were determined by using the
Infinity Glucose Hexokinase Liquid Stable Reagent. Four, retroperitoneal fat pads
rather than abdominal fat pads were removed and weighed.
Our past experiments have found that non-fasting plasma insulin levels are lower
in animals fed the RS diet compared to the controls, and abdominal, perirenal, and brown
fat pad weights are decreased in animals fed the RS diet. Epididymal fat pad weights
have also been shown to decrease with a RS diet (Kishida, Nogami, Himeno, & Ebihara,
2001; Pawlak, Bryson, Denyer, & Brand-Miller, 2001). The protocol was submitted to
and approved by the Institutional Animal Care and Use Committee (IACUC) of
Pennington Biomedical Research Center in Baton Rouge, Louisiana (Appendix C & D).

49

Humoral Analysis
Trunk blood was collected in 4 mL BD Vacutainer Plus tubes spray-dried with
K2 EDTA with Hemogard Closures for plasma collection (Becker, Dickinson & Co.,
Franklin Lakes, NJ) and 13 mL standard test tubes for serum collection at decapitation.
Samples were immediately placed on ice and later centrifuged at 4000 rpm at 4°C for 20
minutes. Plasma and serum samples were stored at –80°C until use for analyses.
Catecholamine Measurements. Plasma epinephrine and norepinephrine were
determined by using a reverse-phase high-performance liquid chromatography with
electrochemical detection (HPLC-EC). The HPLC-EC system operated with the
Coulochem II Model 5600A detector, Solvent Delivery Module Model 582 pump, Guard
Cell with single channel Model 5020, and Autosampler Model 542. The solvent, which
contained methanol, phosphate buffer, and ion-pairing agent, used in this system was
provided in the analysis kit [solvent: CAT-A-PAHSE #45-0180; Kit: Plasma
Catecholamine Analysis Kit (ESA Inc., Chelmsford, MA)]. The method for
catecholamine measurement was performed as described in the methodology booklet
included with the kit. The CoulArray Software (version 1.04) was used to analyze the
data. All samples were analyzed in dup licates.
RIA Measurements. Radioimmunoassay (RIA) kits were used to determine
plasma and serum levels of glucagon (Glucagon RIA Kit, LINCO Research Inc., St.
Charles, MO), insulin (Sensitive Rat Insulin RIA Kit, LINCO Research Inc., St. Charles,
MO) and corticosterone (ImmuChem Double Antibody Corticosterone 125 I RIA Kit,
ICN Biomedicals, Inc., Costa Mesa, CA). The procedures for glucagon, insulin, and
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corticosterone measurements were performed as described in the methodology booklet
included with the kits. All samples were performed in duplicates.
Plasma Glucose Measurements. Plasma and serum glucose was measured with
the Infinity Glucose Hexokinase Liquid Stable Reagent (Thermo DMA, Louisville,
CO). The procedure for glucose measurement was performed as described in the
methodology booklet included with the package, however, a microplate reading
instrument was used to analyze multiple samples rather than an individual sample during
one reading. Although the incubation time ranged from 5-25 minutes across all samples
and standards, the reaction was stable because Glucose Hexokinase reagents have a final
reaction mixture stability of approximately 30 minutes. In addition, linear standards were
used to control for the possibility in variation due to the large incubation time range. The
samples were measured in duplicates (i.e., one of each sample per plate).
Statistical Analysis
Data were analyzed using Statistical Analysis Software version 8.2 (SAS). Means
+ standard error means (+SEM) of all variables were computed for each of the groups.
Repeated measurements of variance were used for daily wheel running with day as the
repeated measure. One-way analysis of variance (ANOVA) was performed on all other
factors as well as cumulative wheel running to determine whether there were significant
main effects of treatment among all the groups. Observed results were considered
statistically significant if the probability of chance occurrence was p<0 .05. When oneway ANOVA indicated statistical significance, a post-hoc Tukey’s Test was used to
determine significant differences among treatment means and whether significant
interaction(s) occurred.

51

CHAPTER 4
RESULTS
The results of experiment one were flawed due to uncontrollable environmental
conditions and inefficient supervision of laboratory systems (see Appendix E for further
explanation); therefore, experiment one and the results of experiment one will not be
mentioned hereafter. The results presented below will represent only that of experiment
two.
Body Weight
Tables 2, 3 and 4 provide data for the average total change in body weight
(+SEM) from day 0 to last day of the study. There were no significant differences in
initial body weights among the eight treatment groups at the beginning of the study (data
not shown; p>0.05). However, by the end of the study, there was a significant difference
in body weight between diet groups, between feeding groups, and between activity
groups as well as a significant diet*feeding interaction. As illustrated in Figure 4,
animals fed the resistant starch (RS) diet had lower body weights than those fed the
control (C) diet (p=0.002) throughout most of the study period. The animals on the
restricted feeding (RF) schedule lost weight while the animals fed ad libitum (AL) gained
weight by the end of the study (p<0.0001) (Tables 2 and 3). Likewise, the exercising
animals lost weight and the sedentary animals gained weight by the end of the study
(p=0.001) (Tables 2 and 3). Lastly, as shown in Figure 5, AL animals fed the RS-diet
gained approximately the same amount of body weight as the AL animals fed the C-diet;
however, RF animals of the RS-diet lost 2x more weight than RF animals of the C-diet
(p=0.002).
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Food Intake
Ad Libitum Feeding. Table 2 provides data on caloric intake and food intake
expressed as mean cumulative (day 0-4) kilocalories (kcal) per kilogram (kg) of body
weight (+SEM) and mean cumulative (day 0-4) grams (g) per kg of body weight (+SEM),
respectively, for AL animals. On day 0-1, diet and activity had a significant main effect
on caloric intake for AL animals (data not shown). Animals fed the RS-diet consumed
15% less kilocalories than those fed the C-diet (p=0.002). Exercising animals consumed
12% fewer kilocalories than the sedentary animals (p=0.008). However, on day 0-1, only
activity had a significant main effect on food intake (data not shown). Exercising
animals consumed 12% less food than the sedentary animals (p=0.01).
On day 3-4, diet and activity continued to have a significant main effect on caloric
intake for AL animals (Table 2). Animals fed the RS-diet still consumed 15% less
kilocalories than those fed the C-diet (p<0.0001); however, exercising animals only
consumed 8% fewer kilocalories than the sedentary animals (p=0.03). Nevertheless, diet
did not have a main effect on food intake, as did activity (Table 2). Exercising animals
consumed nearly 8% less food when compared to sedentary animals (p=0.02).
Restricted Feeding. Table 3 provides information for caloric intake and food
intake expressed as mean cumulative (day 0-4) kcal/kg of body weight (+SEM) and mean
cumulative (day 0-4) g/kg of body weight (+SEM), respectively, for RF animals. On day
1, diet and activity did not have a significant main effect on food consumption (kcal and
grams) for RF animals (data not shown). However, on day 4, there were significant main
effects of diet and activity as well as a significant diet*activity interaction for caloric
intake in animals on the RF schedule. Animals fed the RS-diet consumed 16% fewer
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Table 2. Body Weight Change and Cumulative Food Intake (Ad Libitum)
Ad Libitum
Control
Non-runners
Runners
Total Body
Weight Change
(g)
Cumulative
Food Intake
(g/kg)
Cumulative
Food Intake
(kcal/kg)

Resistant Starch
Non-runners
Runners

42.1 + 2.3

30.3 + 2.3

38.8 + 2.9

33.2 + 3.3

395 + 10a

347 + 12b

396 + 9a

384 + 16a,b

1486 + 44a

1312 + 48a,b

1202 + 38b

1162 + 54b

Note: Total body weight change represents weight change from day 0 to day of kill;
cumulative data represents day 0 to day 4 (thereafter, inanition interferes with accuracy of
representation); values are expressed as mean + SEM; significant differences at p<0.05
are indicated by a, b (Tukey-Kramer Test); n=7

Table 3. Body Weight Change and Cumulative Food Intake (Restricted Feeding)
Restricted Feeding
Control
Non-runners
Runners
Total Body
Weight Change
(g)
Cumulative
Food Intake
(g/kg)
Cumulative
Food Intake
(kcal/kg)

Resistant Starch
Non-runners
Runners*

(16.5) + 3.1a

(30.8) + 3.3a

(36.6) + 2.6a

(66.1) + 15.4b

167 + 12a,b

178 + 10a,b

205 + 14a

145 + 10b

625 + 44a

636 + 22a

616 + 42a

444 + 30b

Note: Total body weight change represents weight change from day 0 to day of kill;
cumulative data represents day 0 to day 4 (thereafter, inanition interferes with accuracy of
representation); values are expressed as mean + SEM; ( ) indicates weight loss;
significant differences at p<0.05 are indicated by a, b (Tukey-Kramer Test); n=7 unless
otherwise specified; *n=6
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Table 4. Body Weight Change, Cumulative Wheel Running, and Cumulative
Food Intake (Runners)
Runners
Total Body
Weight Change
(g)
Cumulative
Wheel Running
(revolutions)
Cumulative
Food Intake
(g/kg)
Cumulative
Food Intake
(kcal/kg)

Control
Ad Libitum
Restricted-Fed
a
30.3 + 2.3
(30.8) + 3.3b

Resistant Starch
Ad Libitum
Restricted-Fed*
a
33.2 + 3.3
(66.1) + 15.4c

5039 + 392a

14290 + 1331b

7612 + 910a

18677 + 2445b

347 + 12a

178 + 10b

384 + 16a

145 + 10b

1312 + 48a

636 + 22b

1162 + 54a

444 + 30c

Note: Total body weight change represents weight change from day 0 to day of kill;
cumulative data represents day 0 to day 4 (thereafter, inanition interferes with accuracy of
representation); values are expressed as mean + SEM; ( ) indicates weight loss;
significant differences at p<0.05 are indicated by a, b, c (Tukey-Kramer Test); n=7 unless
otherwise specified; *n=6

kilocalories than those fed the C-diet (p=0.01). Exercising animals consumed
approximately 13% fewer kilocalories than the sedentary animals (p=0.03). As
demonstrated in Figure 6, there were no significant differences between sedentary and
exercising animals fed the C-diet (p=1.0). However, exercising animals fed the RS-diet
consumed 28% less kilocalories than the sedentary animals (p=0.02). Exercising animals
fed the C-diet ate approximately 30% more kilocalories than the exercising animals fed
the RS-diet (p=0.004).
On the other hand, there was only a significant main effect of activity and a
significant diet*activity interaction for food intake for animals on the RF schedule.
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Figure 4. Daily Body Weight (Control vs. Resistant Starch diet)
Note: C=control diet; RS=resistant starch diet; day 0 represents the start of the
experiment; values represent mean g per day + SEM

Exercising animals consumed 13% less food than the sedentary animals (p=0.04). As
shown in Figure 7, there were no differences in food intake between sedentary and
exercising animals fed the C-diet (p=0.9); however, exercising animals fed the RS-diet
ate roughly 29% less food than the sedentary animals (p=0.006). There were no
differences of food consumption between ABA animals of each diet group (p=0.21).
Activity. Table 4 provides information for caloric intake and food intake in mean
cumulative (day 0-4) kcal/kg of body weight (+SEM) and mean cumulative (day 0-4)
g/kg of body weight (+SEM), respectively, for exercising animals. On day 3-4, there
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Total Body Weight Change
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Figure 5. Total Body Weight Change (Diet x Feeding)
Note: C=control diet, RS=resistant starch diet; significant differences (TukeyKramer Test; p<0.05) are represented by A, B, C; values represent mean grams +
SEM

were significant main effects of diet and feeding schedule on caloric intake for exercising
animals. Animals fed the RS-diet consumed 18% less kilocalories than those fed the Cdiet (p=0.0003). Also, animals on the RF schedule consumed 56% fewer kilocalories
than those AL-fed (p<0.0001).
Additionally, on day 3-4, there was a significant main effect of feeding and a
significant diet*feeding effect on food intake for exercising animals. Animals on the RF
schedule consumed 56% less food than those AL-fed (p<0.0001). As shown in Figure 8,
AL-fed animals fed the C-diet consumed 10% less food than AL-fed animals fed the RS-
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Cumulative Food Intake (Restricted-fed)
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Figure 6. Cumulative Food Intake for RF in kcal/kg (diet x activity)
Note: C=control diet, RS=resistant starch diet, RF=restricted feeding; significant
differences (Tukey-Kramer Test; p<0.05) are represented by A and B; this
illustration represent animals on the restricted feeding schedule; values are
expressed as mean cumulative Kcal/kg + SEM

diet; however, RF animals fed the C-diet consumed 18% more food than RF animals of
the RS-diet (p=0.009).
Wheel Running
Table 4 provides information for the average cumulative wheel running
revolutions (+SEM) from day 0 to day 4 of the study. Throughout the study period, there
was a significant main effect of diet and feed on wheel running. On day 0-1, animals fed
the RS-diet ran 1.4x more than those fed the C-diet (p=0.005) (Figure 9a). Also, RF
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Figure 7. Cumulative Food Intake for RF in g/kg (diet x activity)
Note: C=control diet, RS=resistant starch diet, RF= restricted feeding; significant
differences (Tukey-Kramer Test; p<0.05) are represented by A and B; this
illustration represent animals on the restricted feeding schedule; values are
expressed as mean cumulative g/kg + SEM

animals ran 1.4x more than those fed AL (p=0.005) (Figure 9b). By day 3-4, animals fed
the RS-diet continued to run approximately 1.4x more (daily and cumulatively) than
those fed the C-diet (p=0.03) (Figure 9a); however, the animals on the RF schedule ran
2.6x more (daily and cumulatively) than those fed AL (p<0.0001) (Figure 9b).
Figure 10 illustrates the running pattern for days 0-4 that the animals
demonstrated during the study period. By day 3-4, the animals on the AL feeding
schedule of both the RS-diet and C-diet did not significantly increase their daily activity
since day 0-1 (p=1.00); however, animals on the RF schedule in both diets increased their
daily wheel running significantly when compared to activity on day 0-1 (p<0.05), with
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Figure 8. Cumulative Food Intake for Runners in g/kg (diet x feeding)
Note: C=control diet, RS=resistant starch diet; significant differences (TukeyKramer Test; p<0.05) are represented by A and B; this illustration represents
exercising animals; values are expressed as mean cumulative g/kg + SEM

the ABA animals fed the C-diet and RS-diet significantly increasing their activity as early
as day 2-3 and 1-2, respectively (p=0.002 and p<0.0001).
Tissue Weights and Fat Pad Weights
Thymus, Spleen, and Liver. Tables 5 and 6 provide data of the mean weights
(+SEM) for thymus, spleen, and liver expressed in grams per kilogram of body weight.
There was a significant main effect of diet, feeding schedule, and activity on the thymus,
spleen, and liver weights. Animals fed the RS-diet had 1.3x, 1.2x, and 1.2x lower
thymus, spleen, and liver weights, respectively, compared to the animals fed the control
diet (p<0.0001). The RF schedule decreased the thymus, spleen, and liver weights by
2.3x, 1.7x, and 1.4x, respectively, compared to the animals fed ad libitum (p<0.0001).
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Figure 9a. Daily Wheel Revolutions (C vs. RS)
Figure 9b. Daily Wheel Revolutions (AL vs. RF)
Note: C=control diet, RS=resistant starch diet, AL=ad libitum, RF=restricted
feeding; this figure represents mean daily wheel revolutions + SEM rather than
cumulative running (see Table 4 for cumulative running data)
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Figure 10. Daily Wheel Revolutions
Note: c=control diet, rs=resistant starch diet, AL=ad libitum, RF=restricted feeding;
this figure represents mean daily wheel revolutions + SEM rather than cumulative
running (see Table 4 for cumulative running data); * significant difference (see text)

Exercising animals had 1.2x, 1.1x, and 1.1x lower thymus, spleen, and liver weights,
respectively, compared to the sedentary animals (p=0.002, p=0.003, p=0.039,
respectively).
In addition, there was a significant diet*feeding (p=0.002), activity*feeding
(p=0.003), and diet*feeding*activity (p=0.009) interaction for thymus weights. RF
animals fed the C-diet had 1.8x lower thymus weights than those AL-fed; however, the
RF animals fed the RS-diet had 3.2x lower thymus weights than those AL-fed. In
animals fed AL, exercising did not greatly affect the thymus weights when compared to
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Table 5. Tissues and Fat Pad Weights (Ad Libitum)

Ad Libitum
Control
Non-Runners
Runners

Resistant Starch
Non-Runners
Runners

Thymus

3.3 + 0.2

3.4 + 0.2

3.3 + 0.2

3.1 + 0.2

Spleen

3.2 + 0.1

3.3 + 0.1

3.1 + 0.1

3.1 + 0.2

Liver

38.4 + 1.4

37.3 + 0.8

34.0 + 0.9

34.9 + 1.0

7.9 + 0.1

7.9 + 0.2

7.7 + 0.2

7.6 + 0.2

Adrenal Glands

0.19 + 0.03

0.19 + 0.01

0.17 + 0.02

0.22 + 0.02

Retroperitoneal
Fat
Epididymal Fat

1.69 + 0.35a

0.80 + 0.16a,b

1.08 + 0.15a,b

0.40 + 0.10b

6.84 + 0.55a

4.86 + 0.28b,c

5.58 + 0.34a,b

3.45 + 0.54c

Perirenal Fat

1.25 + 0.14a

0.93 + 0.07a,b

0.98 + 0.07a,b

0.69 + 0.03b

Brown Fat

1.57 + 0.14

1.63 + 0.08

1.40 + 0.08

1.46 + 0.07

Kidneys

Note: Values are expressed as mean g/kg + SEM; significant differences at p<0.05
are indicated by a, b, c (Tukey-Kramer Test); n=7

the sedentary animals (3.24g/kg vs. 3.27g/kg, respectively); conversely, in RF animals,
exercising animals had 1.65x lower thymus weights than the sedentary animals. In
exercising animals on the RF schedule, those fed the C-diet had 2.5x lower thymus
weights than their sedentary AL-fed controls and those fed the RS-diet had 3.8x lower
thymus weights than their sedentary AL-fed animals. Furthermore, in sedentary animals,
animals on the RF schedule and fed the C-diet had only 1.3x lower thymus weights than
the sedentary AL-fed animals, while animals on the RF schedule and fed the RS-diet had
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Table 6. Tissues and Fat Pad Weights (Restricted Feeding)

Restricted Feeding
Control
Resistant Starch
Non-Runners
Runners
Non-Runners
Runners*
Thymus

2.4 + 0.2a

1.3 + 0.1b

1.1 + 0.1b

0.9 + 0.1b

Spleen

2.5 + 0.1a

1.9 + 0.1b

1.8 + 0.1b,c

1.3 + 0.1c

Liver

29.6 + 0.8a

28.2 + 1.4a

25.5 + 0.5a,b

20.7 + 1.4b

7.7 + 0.2

8.2 + 0.2

7.8 + 0.1

8.7 + 0.4

Adrenal Glands

0.25 + 0.02

0.26 + 0.02

0.31 + 0.03

0.37 + 0.05

Retroperitoneal
Fat
Epididymal Fat

0.51 + 0.43

0+0

0+0

0+0

1.64 + 0.39

0.59 + 0.19

0.57 + 0.17

0.30 + 0.12

Perirenal Fat

0.45 + 0.13

0.35 + 0.13

0.38 + 0.10

0.09 + 0.06

Brown Fat

1.50 + 0.09a

1.33 + 0.09a

1.26 + 0.06a,b

0.90 + 0.10b

Kidneys

Note: Values are expressed as mean g/kg + SEM; significant differences at p<0.05
are indicated by a, b, c (Tukey-Kramer Test); n=7 unless otherwise specified; *n=6

nearly 3x lower thymus weights than the sedentary AL-fed animals. Exercising animals
on the RF schedule and fed the RS-diet had nearly 1.5x lower thymus weights than those
fed the C-diet, but this finding was non-significant.
There was also a significant diet*feeding (p=0.003) and activity*feeding
(p<0.001) interaction for spleen weights. In the C-diet, animals on the RF schedule had
1.5x lower spleen weights than those fed AL. In the RS-diet, animals on the RF schedule
had more than 2x lower spleen weights than those fed AL. In animals fed AL, the spleen
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weights for exercising animals was only slightly different from the sedentary animals
(3.21g/kg vs. 3.16g/kg, respectively); however, in animals on the RF schedule, the spleen
weights for exercising animals was nearly 1.4x lower than the sedentary animals. There
were no significant interactions for liver weights.
Kidneys and Adrenal Glands. Tables 5 and 6 provide data of the mean weights

(+SEM) of the kidney and adrenal glands expressed as grams per kilogram of body
weight. Feeding schedules had a significant main effect on both the kidneys and adrenal
glands (p=0.02 and p<0.0001, respectively). In animals on the RF schedule, kidney and
adrenal gland weights were 1.04x and 1.6x higher, respectively, than those AL-fed.
Exercising had a significant main effect on kidney weight (p=0.04) but not for adrenal
gland weights (p=0.10). Exercising animals had 1.04x higher kidney weights than those
that were sedentary. On the other hand, diet only had a significant main effect on adrenal
gland weights (p=0.03) but not for kidney weights (p=0.91). Animals on the RS-diet had
1.2x higher adrenal weights than those fed the C-diet.
There was a significant activity*feeding interaction for kidney weights (p=0.02).
In animals on the RF schedule, those that exercised had 1.1x higher kidney weights than
those that were sedentary. However, in AL-fed animals, both exercising and sedentary
animals had similar kidney weights with the exercising animals having slightly lower
kidney weights than the sedentary animals (7.73g/kg and 7.78g/kg, respectively). In
addition, there was a significant diet*feeding interaction for adrenal gland weights
(p=0.03). In the C-diet, RF animals had only 1.4x higher adrenal weights than those ALfed. In the RS-diet, RF animals had 1.8x higher adrenal weights than those fed AL.
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Retroperitoneal Fat, Epididymal Fat, and Perirenal Fat. Tables 5 and 6

provide information of the mean weights (+SEM) of retroperitoneal, epididymal, and
perirenal fat pad weights in grams per kilogram of body weight. There was a significant
main effect of diet, feeding schedule, and activity on retroperitoneal, epididymal, and
perirenal fat pad weights. Animals fed the RS-diet had approximately 2x, 1.4x, and 1.4x
lower retroperitoneal, epididymal, and perirenal fat pad weights, respectively, when
compared to those fed the C-diet (p=0.0179, p=0.0003, and p=0.0044, respectively).
Animals on the RF schedule had over 7.5x, 6.5x, and 3x lower retroperitoneal,
epididymal, and perirenal fat pad weights, respectively, than those AL-fed (p<0.0001).
Exercising animals had 2.7x, 1.6x, and 1.5x lower retroperitoneal, epididymal, and
perirenal fat pad weights, respectively, when compared to sedentary animals (p=0.0015,
p<0.0001, and p=0.0008, respectively).
Although there were no significant interactions for retroperitoneal and perirenal
fat weights, there was a significant activity*feeding interaction for epididymal fat pad
weights (p=0.0091). In sedentary animals, RF decreased epididymal fat weights by
nearly 6x the weight of those AL-fed. In exercising animals, RF decreased epididymal
fat weights by approximately 9x the fat weight of those AL-fed.
Brown Fat. Tables 5 and 6 provide data for mean brown fat pad weights (+SEM)

in grams per kilogram of body weight. Both diet and feeding had significant main effects
on brown fat pad weights. Animals fed the RS-diet had about 1.2x lower brown fat
weights than those fed the C-diet (p=0.0003). Likewise, animals on the RF schedule had
approximately 1.2x lower brown fat weights than those AL-fed (p=0.0001). In addition,
there was a significant interaction between activity and feeding (p=0.02) for brown fat
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Figure 11. Brown Fat (activity x feeding)
Note: AL=ad libitum, RF=restricted feeding; significant differences (Tukey-Kramer
Test; p<0.05) are represented by A and B; values are expressed as mean g/kg +
SEM

pad weights. In AL-feeding, exercising increased the weights of brown fat only slightly
when compared to the sedentary animals (1.55g/kg vs. 1.49g/kg, respectively); however,
in RF, exercising animals had approximately 1.2x lower weights for brown fat compared
to sedentary animals (Figure 11).
Stress Hormones (Epinephrine, Norepinephrine, and Corticosterone)

Tables 7 and 8 provide information for mean epinephrine, norepinephrine, and
corticosterone levels (+SEM). Overall, exercising and feeding schedule had a significant
effect on epinephrine, norepinephrine, and corticosterone levels. Exercising animals had
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Table 7. Hormones and Plasma Glucose Levels (Ad Libitum)

Ad Libitum
Control
Non-Runners
Runners
Epinephrine
(ng/mL)
Norepinephrine
(ng/mL)
Corticosterone
(ng/mL)
Glucagon
(pg/mL)
Insulin (ng/mL)
Plasma glucose
(mg/dL)

Resistant Starch
Non-Runners
Runners

2.06 + 0.26

2.40 + 0.51

1.44 + 0.16

2.36 + 0.33

1.08 + 0.15

1.47 + 0.26

0.79 + 0.06

1.01 + 0.12

791 + 161

1000 + 169

601 + 106

1207 + 154

56 + 8

49 + 8

116 + 12

92 + 10

0.77 + 0.08

0.96 + 0.41

0.53 + 0.04

0.52 + 0.04

183 + 14

170 + 7

179 + 16

177 + 14

Note: Values are expressed as mean + SEM; significant differences considered at
p<0.05 (Tukey-Kramer Test); n=7

1.4x, 1.3x, and 1.9x more epinephrine, norepinephrine, and corticosterone levels,
respectively, than sedentary animals (p<0.05, p=0.02, and p=0.02, respectively).
Additionally, those on the RF schedule had 1.5x, 1.8x, and 2.4x higher epinephrine,
norepinephrine, and corticosterone levels, respectively, than those fed AL (p=0.0003,
p<0.0001, and p<0.0001, respectively).
Diet did not have a significant main effect on epinephrine, norepinephrine, and
corticosterone levels (p=0.25, p=0.27, and p=0.70, respectively); however, it did have a
significant interaction with the feeding schedule (p=0.002) as well as with the feeding
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Table 8. Hormones and Plasma Glucose Levels (Restricted Feeding)

Restricted Feeding
Control
Resistant Starch
Non-Runners
Runners
Non-Runners
Runners
Epinephrine
(ng/mL)
Norepinephrine
(ng/mL)
Corticosterone
(ng/mL)
Glucagon
(pg/mL)
Insulin (ng/mL)
Plasma glucose
(mg/dL)

3.25 + 0.73

3.27 + 0.84

3.38 + 1.06

6.10 + 1.20^

1.75 + 0.26a

1.51 + 0.24a

1.17 + 0.26a

2.99 + 0.57b^

1705 + 353

2373 + 701

1777 + 195

2647 + 403*

39 + 4a

73 + 28a,b

80 + 11a,b

173 + 86b*

0.40 + 0.01

0.39 + 0.01

0.38 + 0

0.37 + 0*

140 + 14

117 + 14

115 + 12

97 + 22^

Note: Values are expressed as mean + SEM; significant differences at p<0.05 are
indicated by a, b (Tukey-Kramer Test); n=7 unless otherwise specified; *n=6; ^n=4

schedule and activity (p=0.022) for norepinephrine levels only. In the C-diet, animals on
the RF schedule produced roughly 1.3x more norepinephrine levels than those fed AL
while in the RS-diet, animals on the RF schedule produced approximately 2.6x the
norepinephrine levels than the animals AL-fed. Figure 12 demonstrates a significant
diet*feeding*activity interaction. In the C-diet, there were no significant differences in
norepinephrine levels between exercising and sedentary animals on the RF schedule
(p=0.99); however, in the RS-diet, exercising animals on the RF schedule had 1.7x higher
norepinephrine levels than sedentary RF animals (p=0.04). In addition, RS-diet,
exercising RF animals had nearly 4x higher levels of norepinephrine than its respective
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Norepinephrine
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0
Non-Run

Run

Non-Run

Control

Run

Resistant Starch

Figure 12. Norepinephrine (diet x feeding x activity)
Note: AL=ad libitum, RF=restricted feeding, C=control diet, RS=resistant starch
diet; values are expressed as mean ng/mL + SEM

controls (p<0.0001). ABA animals fed the RS-diet had nearly 2x the level of
norepinephrine than the ABA animals fed the C-diet (p=0.007).
Diet Hormones and Glucose
Glucagon. Tables 7 and 8 also show data for mean glucagon levels (+SEM).

Diet had a significant main effect on plasma glucagon levels with animals on the RS-diet
having 1.7x higher levels than those fed the C-diet (p=0.001). Activity and feeding
schedule did not have a significant main effect on glucagon levels among the treatment
groups (p=0.25 and p=0.60, respectively); however, there was a significant
activity*feeding interaction for glucagon levels (p=0.02). In AL-fed animals, plasma
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glucagon levels were approximately 1.2x lower for the exercising animals when
compared to the sedentary animals. In RF animals, plasma glucagon levels for exercising
animals were more than 2x higher than that of the sedentary animals.
Insulin and Plasma Glucose. Tables 7 and 8 show data for mean insulin and

plasma glucose levels (+SEM). There was a significant main effect of feeding on insulin
and plasma glucose levels. Animals on the RF schedule had 1.8x and 1.5x lower levels
of insulin and plasma glucose levels, respectively, when compared to AL-fed animals
(p=0.006 and p<0.001, respectively). Diet and activity did not have any significant main
effects or interactions on insulin and plasma glucose levels (p>0.10).
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CHAPTER 5
DISCUSSION
The present study was designed to determine whether resistant starch could
ameliorate the outcomes of the activity-based anorexia (ABA) model. The results of the
experiment also served to validate this specific procedure as an ABA paradigm.
Consistent with many previous studies, young, male rats from our study exhibited
decreased food intake, reduced body weight, and elevated wheel running when exposed
to ABA conditions (Beneke et al., 1995; V. R. Burden et al., 1993; Doerries et al., 1991;
Dwyer & Boakes, 1997; Epling & Pierce, 1984; Lett et al., 2001; Routtenberg &
Kuznesof, 1967; Tokuyama et al., 1982). Additionally, similar to many other studies, the
ABA paradigm increased the weights of the adrenal glands and decreased the weights of
the thymus glands (V. R. Burden et al., 1993; Hara et al., 1981; Ness et al., 1995) and
spleens (Hara et al., 1981). Moreover, ABA demonstrated reduced body fat when
compared to other treatment groups (V. R. Burden et al., 1993). Comparable to other
studies, the resistant starch (RS) diet independently decreased retroperitoneal,
epididymal, perirenal, and brown adipose tissue (de Deckere, Kloots, & van Amelsvoort,
1995; Francis et al., 2003; Hegsted et al., 2003; Kishida et al., 2001; Pawlak et al., 2001).
Lastly, as expected, ABA animals demonstrated elevated levels of catabolic hormones
compared to controls (V. R. Burden et al., 1993; Licinio et al., 1996).
Although the ABA outcomes were consistent with many earlier studies, the study
did not support our hypothesis that resistant starch (RS) will attenuate the anorexic
effects of the ABA model; rather RS exacerbated the conditions of anorexia in these rats.
The effects described above were reported at a greater extent in animals fed the RS-diet
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than the animals fed the control (C) diet. For example, the ABA animals of the RS-diet
group lost an average of 22% and 28% of their pre-experimental body weight, whilst the
ABA animals of the C-diet lost an average of 15% and 20% of their initial weight by
days 3 and 4, respectively (pre-experimental data not shown). By the end of the
experiment (day 5 or 6), the ABA animals fed the RS-diet significantly lost twice as
much weight than did the ABA animals fed the C-diet.
In addition, on day 3-4, cumulative data shows that RS-fed ABA animals ran
roughly 24% more and ate approximately 19% less g/kg (or 30% less kcal/kg) when
compared to ABA animals given the C-diet. Furthermore, sedentary animals on the
restricted feeding (RF) schedule in the RS-diet group lost 16% more weight by the end of
the study while consuming only 3% less kcal/kg on day 3-4 than did the ABA animals
fed the C-diet. A past study by Roy and lab demonstrated that rats fed a low-energy
density diet increased food intake to increase energy consumption (H. J. Roy et al.,
2003). In this study, ABA animals fed the RS-diet consumed significantly less kcal/kg
than did the ABA animals fed the C-diet. Also, the RS-diet, in combination with the
ABA paradigm, initiated a significant reduction in brown fat as well as an elevation of
norepinephrine levels. These findings strongly show that the resistant starch diet resulted
in an accelerated progression to anorexia when used in conjunction with the ABA
paradigm.
To our knowledge, studies regarding ABA with respect to diet composition are
limited; thus, we attempted to manipulate the diet to examine the possible outcomes.
Although RS has been shown to decrease fat pad weights (de Deckere et al., 1995;
Francis et al., 2003; Hegsted et al., 2003; Kishida et al., 2001; Pawlak et al., 2001), it has
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also been shown to display a gradual rise and steady leveling of post-prandial blood
glucose responses rather than producing the transient hyperglycemia and transient
hypoglycemia periods as would a high glycemic starch diet (Behall & Hallfrisch, 2002;
Hallfrisch & Behall, 2000; Raben, Tagliabue et al., 1994). This demonstration of glucose
control may influence the rate of hormone production and secretion, particularly the
catabolic hormones (J. E. Hall & Adair, 1998), thereby suggesting that incorporation of
resistant starch into the diet can regulate the breakdown and mobilization of energy
stores.
In a past study, rats were fed at the onset of the dark cycle and killed at the onset
of the dark cycle. The researchers reported significant differences in glucose and insulin
responses between ad libitum (AL) and RF treatments (V. R. Burden et al., 1993).
Conversely, in our study, the meal period preceded the onset of the dark cycle and the
animals were killed at that time as well. There were no significant differences between
levels of insulin in ABA animals compared to their respective controls; however, the
levels of plasma glucose levels were significantly reduced in ABA animals compared to
their controls. It was expected that the glucose levels of the ABA animals on the RS-diet
would be higher than those on the C-diet due to the ability of RS to maintain a steady
glucose level. However, because the ABA animals from both diet groups were fasted for
at least 22.5 hours, it is suggested that the glucose levels of the ABA animals on the RSdiet declined to the levels similar to those on the C-diet. Perhaps, if the samples were
taken some hours earlier, there would have been a significant difference between the two
ABA groups.
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It has been well established that in order to raise blood glucose levels and produce
energy for bodily needs, catabolic hormones such as glucagon, norepinephrine,
epinephrine, and corticosterone work similarly to promote glycogenolysis and
gluconeogenesis, increase lipolysis and ketogenesis, and decrease cellular uptake of
glucose (Groff & Gropper, 2000; J. E. Hall & Adair, 1998). We proposed that if the
blood glucose levels were maintained at euglycemic levels, the production and release of
these catabolic hormones would not be necessary at an elevated rate and the body’s
energy storage will not be utilized to a great extent.
In our study, the levels of norepinephrine, epinephrine, and corticosterone
significantly increased in ABA rats fed the RS-diet when compared to their respective
controls. Moreover, only the norepinephrine leve ls of ABA animals fed the RS-diet were
significantly higher than the ABA animals fed the C-diet. On the other hand, only
corticosterone levels significantly elevated in ABA rats fed the C-diet compared to their
respective controls. Similarly, Burden and co-authors showed an increase in
corticosterone levels in experimental animals; however, they found norepinephrine levels
to be consistent among all groups (V. R. Burden et al., 1993).

Because the ABA

animals were exercising and restricted of food for a long period of time, immediate
glucose availability was insufficient to meet the demands of the body; therefore, these
animals exhibit high secretions of corticosterone. In contrast to our expectations, the
glucose levels of ABA animals fed the RS-diet were not maintained at a steady,
euglycemic level by the time the meal is usually provided; thus, there were high
elevations of all three catabolic hormones (i.e., corticosterone, norepinephrine, and
epinephrine).
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Because glucagon is a hormone that helps to maintain body ho meostasis during
times of fasting, plasma glucagon levels were suggested to be elevated in the RF animals
(J. E. Hall & Adair, 1998). Contrastingly, in our study, there were no significant
differences between ABA groups and their respective controls. On the other hand, Gee
and associates found that there was no significant effect of RS on plasma glucagon levels
between experimental and control groups (Gee, Faulks, & Johnson, 1991; Gee &
Johnson, 1990). Similarly, there were no significant differences between our control
groups (i.e., sedentary AL- fed animals) or any other corresponding pairs (i.e., sedentary
AL- fed animals, exercising AL- fed animals, sedentary RF animals, or ABA animals)
from each diet treatment. This finding suggests that glucagon may not play a role in
ABA.
In the fasting state, low levels of circulating insulin and increased levels of
norepinephrine and epinephrine promote lipolysis (Groff & Gropper, 2000).
Additionally, catecholamines have been suggested to be associated with corticosterone
(Gillies & Grossman, 1985; Licinio et al., 1996); particularly, corticosterone is proposed
to exert permissive effects on epinephrine and norepinephrine (J. E. Hall & Adair, 1998).
Therefore, we suggest that if all three of these levels are elevated, lipolysis will be further
stimulated (Devenport, Knehans, Sundstrom, & Thomas, 1989; Guyton, 1987).
Evidently, the ABA animals fed RS-diet demonstrated significant elevations of these
catabolic hormones, which were at higher levels than the ABA animals of the C-diet,
thus, contributing to the greater loss of body weight and body fat. However, ABA
animals of the C-diet did not display elevated levels of norepinephrine and epinephrine
levels as they did corticosterone levels. Therefore, it is suggested that the body weight
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and fat reduction occurred at a lesser extent in the ABA animals fed the C-diet compared
to the ABA animals fed the RS-diet because only corticosterone levels were elevated.
Literature indicates that epinephrine is more potent than norepinephrine, which functions
primarily as a neurotransmitter (Groff & Gropper, 2000); therefore, it cannot be
explained why norepinephrine levels in ABA animals fed the RS-diet were higher than
those fed the C-diet, while corticosterone and epinephrine levels were not significantly
different between the two ABA groups.
Exercise tends to increase norepinephrine concentrations; thus it is believed that
exercise- induced food intake suppression has been associated with increased plasma
norepinephrine concentrations (Duncan et al., 1985; Guilland, Moreau, Genet, &
Klepping, 1988; Kohno et al., 2000). Our study supported the idea that elevated exercise
and suppressed food intake both contribute to high norepinephrine levels. The
norepinephrine levels in ABA rats fed the RS-diet were significantly higher than their
respective controls; however, this did not occur in the C-diet. Furthermore, the ABA of
the RS-diet had significantly higher levels of norepinephrine compared to the animals fed
the C-diet. Accompanying these elevated levels of norepinephrine were high levels of
activity and lower amounts of caloric intake when compared to ABA animals fed the Cdiet.
Because the adrenal glands control the secretion of corticosterone, it has been
suggested that if corticosterone release is not regulated, high levels of this hormone can
significantly impair the immune system, thus, leading to atrophy of the thymus glands (J.
E. Hall & Adair, 1998). In our study, ABA animals exhibited lower, atrophic thymus
weights as well as significantly higher levels of corticosterone compared to their
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corresponding controls. In addition, ABA animals of the RS-diet demonstrated
hypertrophic adrenal glands, which further supports the idea that elevated levels of
corticosterone from the adrenal glands may hinder immune functions.
Summary and Conclusion
The purpose of this study was to determine whether resistant starch (RS) can
ameliorate the anorexia associated with the activity-based anorexia (ABA) paradigm. It
was believed that a high GI diet produces transient post-prandial hyper- and hypoglycemia. Conversely, because animals fed RS slowly digest and absorb glucose, they
are able to maintain euglycemia for a longer period of time when compared to those fed a
high GI diet. Therefore, if euglycemia is sustained, there will be less, if any, stimulation
of catabolic hormone release and energy stores will not be catabolized. Higher body
stores are suggested to attenuate wheel running associated with ABA (Fish & Lewis,
1996). Therefore, if the animals are fed a diet containing RS while exposed to the
standard ABA procedure, the effects of the ABA model will be ameliorated.
Our study showed that this specific procedure developed the typical ABA
outcomes in rats. Additionally, the results suggest that the anorexic responses only
occurred when restricted- feeding and exercising were administered together.
Furthermore, when given RS in the diet, these anorexic responses develop at an even
faster rate. Therefore, our diet manipulation suggests a non-beneficial outcome for
anorexia. However, these results also indicate a method to accelerate the outcomes of
ABA.
By the end of the study (day 5 and 6), ABA rats fed the RS-diet had
approximately 30% weight loss compared to the 20% weight loss illustrated by the ABA
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rats fed the C-diet. RS-fed ABA rats ran approximately 24% more and ate 30% less
kcal/kg compared to the ABA rats fed the C-diet. This finding may explain the reason
for the non-significant differences in the adrenal gland weights, brown fat weights,
epinephrine levels, and norepinephrine levels between ABA and control rats fed the Cdiet. In addition, it was expected that the glucose levels of RS- fed rats be at euglycemic
levels; however, meal restriction (22hrs) was probably too severe for the RS- fed ABA
rats to maintain the levels that were expected of the low GI characteristic of RS. The
faster progression to anorexia and cachexia demonstrated by ABA rats fed the RS-diet
can be contributed to low glucose levels, which stimulated corticosterone. Also, food
intake suppression and high activity levels played a role in elevating levels of epinephrine
and norepinephrine. Collectively, elevated levels corticosterone, epinephrine, and
norepinephrine, which have all been implicated in catabolism, contributed to the
outcomes seen RS- fed ABA rats.
Therefore, when animals are restricted-fed and allowed access to the activity
wheels, the combination of these two stress- factors initiates the anorexic and cachexic
responses. This study provided valuable information on the relationship among diet,
activity, and food consumption. In our study, RS accelerated the outcomes of ABA;
therefore, it served as a means to increase the severity of ABA rather than the opposite.
Although RS is not recommended in treatment of activity anorexia, it can be considered
in the treatment of obesity or as a weight loss program.
Future Directions
It is important to determine what characteristics are associated with anorexia.
More specifically, it would be valuable to determine which factors stimulate, accelerate,
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delay, or inhibit the progression to anorexia. Anorexia nervosa is affecting more
individuals at a younger age, particularly females between 9-14 years of age, although
this is not to exclude those at older ages. Abnormally intense exercising and severe
dieting have a dramatic effect on this eating disorder. Therefore, further studies should
be conducted to determine what type of diet can provide more efficient immediate energy
and stored energy in order to delay the cachexia found in individuals diagnosed with
anorexia nervosa. Perhaps a high-energy density diet that provides slow-absorbing
glucose can prove to be beneficial. In addition, studies should focus on causes for the
initiation of the onset of exercise and sustaining of high levels of activity. Lastly, studies
should determine what factors can overcome the exercise-induced food intake
suppression. Nevertheless, psychological aspects are not neglected and should also be
considered.
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LSU PROTOCOL FOR ANIMAL CARE AND USE
Instructions for Submission: MUST BE TYPED! (Use additional sheets if necessary and attach
to this form or use word processor and add lines). SUBMIT ORIGINAL plus 12 COPIES to the
IACUC Office (Rm. 1502 School of Veterinary Medicine).
PROTOCOL NUMBER:

01-086

APPROVAL DATE:
SECTION 1:
Principal Investigator
Office Phone: 578-1518
Name:
Maren Hegsted
Home Phone: 769-3097
Roy Martin

SECTION 2:

Office Phone: 578-2284

E-mail address:
mhegsted@lsu.edu
E-mail address:
rjmartin@lsu.edu

Project Title (Enter the name of your project/course number in the block
below)

The effects of low versus high glycemic index (GI) starch on weight gain and fat accumulation.

SECTION 3:
Animal Species
Strain: Wistar
Zucker
Spague-Dawley

Species: Rat

Number of animals
needed:
Year 1:
Year 2:
TOTAL:

Maximum number
needed
at one time: 80

130
170
300

Year 1 and 2
Wistar – up to 80
Zucker – up to 120
Sprague-Dawley – up
to100
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Number of animals to be placed in
each group: _6 to 10
Year 1
Training: up to 10 rats
Study 1: 10 rats x 4 groups = 40 rats
Study 2: 10 rats x 8 groups = 80 rats
Year 2
Training: up to 10 rats
Study 3: 10 rats x 8 groups = 80 rats
Study 4: 10 rats x 8 groups = 80 rats

Animal housing and veterinary care have been coordinated with DLAM office OR LSU
Agricultural Center Unit.
X YES
NO
Name of Animal Housing Representative Contacted (typed): Laurie Henderson
Signature (required):

Location of Animals
X

DLAM Vivarium

Life Sciences Vivarium

SVM Barns

SVM Fish Building

LAES (List Site):

Other (List Site):

Field Study (Do not complete sections 6, 11, and 12
SECTION 4: Abstract Plan of Research/Teaching
Provide a brief layman’s description of the project in the block below.
There is a possible link between weight gain, fat accumulation, and bone density in a diet
comprising or low versus high glycemic index (GI) foods. We will be testing methodology to
determine optimum procedures and rat strains to be used in future research projects. The rats will
be fed a high GI diet or a low GI diet for 12 weeks. The modifications in GI will be achieved by
using a waxy cornstarch (100% amylopectin) for the high GI diet and Hi-maize (40% amylopectin
and 60% amylose) for the low GI diet. . Amylopectin is rapidly digested in the stomach and small
intestine quickly releasing glucose into the blood stream. Amylose is resistant to amylase
hydrolysis and is fermented in the cecum and colon producing short chain fatty acids, primarily
acetate, butyrate and propionate. Diets will be based on a modified AIN93-G diet with 35% of
calories from fat, 45% from carbohydrate and 20% from protein.
The initial study will consist of 4 diet treatment groups consisting of the two diets (high GI or low
GI) and two feeding methods (meal fed or ad libitum). Meal fed animals will be fed twice daily
with food available for 30 minutes in the morning and one hour in the evening. There will be a
12/12-hour light/ dark cycle set so the evening meal will be offered at the beginning of the dark
cycle. The ad libitum fed rats will have diet available to them 24-hours per day.
Abdominal fat and bone density will be estimated in the beginning and at three-week intervals in
the anesthetized animals using a SABRE peripheral dual energy x-ray absorptiometer (pDEXA).
Non-fasting blood will be drawn through retro orbital sinus bleeding during the first and last
pDexa for leptin analysis. After 12 weeks, rats will be fasted overnight, anesthetized with
isoflurane, and blood drawn by cardiac puncture prior to dissection. Abdominal fat depots and
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liver will be removed, weighed, and frozen in liquid nitrogen. The rat carcass will be eviscerated
and frozen for later proximate analysis. Cecal and colon weight and length will be measured to
determine the effects of amylose on colon growth.
The results from this initial study will determine the optimum feeding method (meal fed vs ad
libitum) to be used in used in the subsequent studies.
STUDY 2, 3, 4:
Once the optimum feeding method (meal feed vs ad libitum) has been determined, future studies
will determine variances between strain (Wistar, Obese Zucker, Lean Zucker, Sprague-Dawley)
and sex (male vs female) using the same diet treatment groups (high GI and low GI). Each study
will be comprised of 6 to 10 animals per grouping. All procedures will be duplicated in the same
manner as stated above.

SECTION 5:

Investigator’s Statement. Assurances for the Humane Care and Use of
Vertebrate Animals.

By signing this form, we agree to abide by the Policy for the Care and Use of Animals of Louisiana
State University, or that of the LSU Agricultural Center. This project will be in accordance with the
NIH “Guide for the Care and Use of Laboratory Animals” (except as explained in the accompanying
protocol), and the Louisiana State University or the LSU Agricultural Center Animal Welfare
Assurance on file with the U.S. Public Health Service.
I further assure the Committee that: 1) I will abide by all federal, state, and local laws and
regulations governing the use of animals in teaching and research; 2) the investigators and
technicians are adequately trained to perform the research techniques required in these
studies; and 3) the fewest number of animals required to produce significant results are being
used in this study.

Principal Investigator Signature

Professor
Title/Rank

11/1/2001
Date

Maren Hegsted
(Type Name of Principal Investigator)
Principal Investigator Signature

Professor
Title/Rank

11/1/2001
Date

R J Martin
(Type Name of Principal Investigator)
Co- Investigator Signature

Professor
Title/Rank

Carol O’Neil
(Type Name of Co- Investigator)
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11/1/2001
Date

Investigator Signature

Associate Professor
Title/Rank

11/1/2001
Date

Co-

Research Associate
Title/Rank

11/1/2001
Date

Co-

Research Associate
Title/Rank

11/1/2001
Date

Co-

Mike Keenan
(Type Name of Co-Investigator)

Investigator Signature
Kathleen L McCutcheon
(Type Name of Co-Investigator)
Investigator Signature
Anne R Francis
(Type Name of Co-Investigator)

Surgeon
applicable) Signature

Title/Rank

(if

Date

(Type Name of Surgeon)
SECTION 6: Special Husbandry Requirements
Do your animals have special needs to be addressed by DLAM?
1.
YES
(F) 70-72
TEMPERATURE
RANGE
LIGHT CYCLE (hours light/hours dark)

Humidity:
12/12

0400-1600 light / 1600-0400 dark

Type:
Size:
CAGIN
G
Stainless Steel wire cages
SINGLE
Type: corncob
Autoclaved? No
BEDDING/LITTE
R
Sterile:
De-ionized:
Acidified:
WATER
DIET

Filter tops required? YES
(During transport for pDexa)
Changes/week:
We will do
Tap:
Other:
YES

Special Feeding Requirements: We will feed

OTHER SPECIAL
NEEDS

2.

(%)

Red incandescent light if available

NO (If you indicate ‘No’, your animals will be cared for according to standard operating
procedures of DLAM)
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3.

Not Applicable

SECTION 7:
Hazardous Materials
Will zoonotic or recombinant, radioactive, or hazardous chemical agents be PRESENT IN THE
ANIMAL ROOM?
Hazardous Chemicals?
Radioisotopes?
Zoonotic/Recombinant
Agents?
YES
X NO
YES
X NO
YES
X NO
Compound(s):
Isotope(s):
Are you certified by the
Agent(s):
Radiation Safety
EXEMPT
Committee?
IBRDS Chairman Signature:
YES
NO
Note: If zoonotic (infectious to humans) or recombinant organisms are to be used, this protocol
request must be submitted to the Biohazardous Materials Safety Committee for approval
PRIOR TO CONSIDERATION by the IACUC. Similarly, if hazardous chemicals are to be
used in the animal room, submit the proposal to the Chemical Safety Committee for prior
approval. P.I. MUST PROVIDE health and safety measures for animal technicians and
facility maintenance personnel. In Standard Operating Procedure (SOP) form, describe any
precautions, procedures, or personal protection required in handling animals or waste
containing listed agents or compounds, or in working in or around the animal room
(including air handling system), and attach a copy of your SOP(s) to this protocol
proposal.
SECTION 8: Summary of Procedures
Your response in this section should provide the reader with a complete description of how every
animal to be used in this project is to be treated during every phase of the study. Your target audience
is a faculty member from a discipline unrelated to yours. Do not use jargon. Please include the
following information:

4.
5.
6.
7.

8.

The rationale for using animals. Why should this study be done? What hypothesis will
be tested?
How and/or why you selected the animal species indicated.
How you arrived at the number of animals to be used.
A complete description of the proposed use of the animals. Describe the experimental
design of the study. Include a list of any physical, chemical or biological agents (name,
dose, volume, route, frequency) that may be administered. Tables and outlines are
helpful to indicate group assignments and study progression.
A description of procedures designed to assure that discomfort and injury to animals
would be limited to that which is unavoidable in the conduct of scientifically valuable
research. Indicate how analgesic, anesthetic, and tranquilizing agents will be used where
appropriate, to minimize discomfort and pain to the animals. It is advisable that you
obtain input from LSU’s Attending Veterinarian (Dr. David Baker) or from another
veterinarian familiar with the species to be used.
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9.
A description of any euthanasia method to be used.
Wistar, Zucker, and Sprague-Dawley Rats will be used as Animal models for evaluating the effects
of variable diets of high or low Glycemic Index starches with constant calorie and protein content.
Male Wistar Rats will be used in the initial study to determine if there is a significant difference in
weight gain, fat accumulation, and bone density between the two starches and between the two
feeding methods. Male Wistar Rats between the ages of 7 to 20 weeks show a higher growth curve
than most strains, so there is a higher probability of weight gain during the 12-week study. This will
allow us to analyze data and make decisions on how to proceed with future studies. Once the
methodology is determined, future studies will compare strain and sex. Male and female Wistar,
Obese Zucker, Lean Zucker, and Sprague-Dawley rats will be used to determine if those results can
be duplicated. By using the selected rat strains as animal models, we are better able to replicate the
variation in human populations. Each study will use the same methodology (diet, light cycle, caging,
and procedures), with the exception of the feeding method (ad libitum vs. meal fed), since the
optimum feeding method will be determined during the initial study.
Rats will be blocked by weight, and randomly assigned to diet treatment groups. Each group will
consist of a minimum of 6 to a maximum of 10 rats per group. The initial study will use 10 animals
per treatment group (4 groups, N=40). Wistar rats are economical, therefore 10 rats per group will
allow for possible loss of animals during anesthesia and retro orbital sinus bleeding. Once we have
perfected these procedures, fewer numbers may be needed per treatment group in future studies. The
final number of rats used for these studies will be determined after analysis of data from the initial
study. An additional ten rats will be ordered from one of the DLAM facilities for training. A DLAM
veterinarian will teach staff and students proper methods for anesthesia, retro-orbital bleeding, heart
puncture and dissection.
The animals will be single housed in wire stainless steel cages. We will measure food intake, and
weigh backs will be used to measure spillage. We will feed all animals and change caging. Clean
water bottles and fresh water will need to be provided at all times by the Lab animal staff.
The rats will be fed a high GI diet or a low GI diet for 12 weeks. The modifications in GI will be
achieved by using a waxy cornstarch (100% amylopectin) for the high GI diet and Hi-maize (40%
amylopectin and 60% amylose) for the low GI diet. . Amylopectin is rapidly digested in the stomach
and small intestine quickly releasing glucose into the blood stream. Amylose is resistant to amylase
hydrolysis and is fermented in the cecum and colon producing short chain fatty acids, primarily
acetate, butyrate and propionate. Amylopectin provides 4 kcal/g as glucose while amylose provides
about 2 kcal/g as fatty acids in fermentation. Diets will be based on a modified AIN93-G diet with
35% of calories from fat, 45% from carbohydrate and 20% from protein.
STUDY 1:
4 diet treatment groups with 10 Male Wistar rats randomly assigned to each group:
1) High GI, meal fed
2) Low GI, meal fed
3) High GI, ad libitum fed
4) Low GI, ad libitum fed
The meal fed animals will be fed twice daily with food available from 0830 to 0900 in the morning
and from 1600-1700 in the afternoon. The light dark cycle will be light from 0400-1600 and dark
from 1600-0400 so the one-hour evening meal will be offered at the beginning of the dark cycle. The
ad libitum fed rats will have diet available to them 24-hours per day with food intake, including
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spillage, recorded three times weekly. All Rats will be weighed three times per week. Future studies
will use 2 diet treatment groups using the Low GI and High GI diets stated above, and one feeding
method.
Isoflurane will be used for anesthesia. Artificial tear ointment will be used in both eyes of each rat
while anesthetized to prevent eye damage. Abdominal fat and bone density will be estimated at the
beginning and at three-week intervals in the anesthetized animals using a SABRE peripheral dual
energy x-ray absorptiometer (pDEXA). During the first and last pDEXA, while still under anesthesia,
400ul of blood will be drawn through retro orbital sinus bleeding for leptin analysis. The pDexa
machine is located in the nutrition lab, room 548 of the Life Science building, next to the service
elevator directly under the 6th floor Life Science Vivarium. For each of the five scheduled
procedures, the rats will be brought, four to six at a time, in shoe boxes with micro isolator lids from
their animal room in the Vivarium to the Nutrition lab on the 5th floor. They will be returned
immediately after recovery to their original cage. Additional monitoring will take place after the retro
orbital bleeding is performed. An antibiotic opthalmic ointment will be used to treat any animals with
visible eye irritation.
After 12 weeks, rats will be fasted overnight and moved individually to the necropsy room in the Life
Science Vivarium. They will be anesthetized with isoflurane and up to 10cc of blood drawn by
cardiac puncture with a syringe resulting in termination. Cervical dislocation will assure death prior
to dissection. Abdominal fat depots and liver will be removed, weighed, and frozen in liquid
nitrogen. The rat carcass will be eviscerated and frozen for later proximate analysis. Cecal and colon
weight and length will be measured to determine the effects of amylose on colon growth.
SECTION 9:
Type of Project
TYPE A - Pain or distress will not be induced; animals will only be used for injections,
collections, or procedures causing nothing more than minor discomfort; or will be
humanely euthanized prior to induction of pain or distress.
TYPE B - Pain or distress will be relieved by appropriate therapy.
X
TYPE C - Drug intervention for pain or distress would interfere with the protocol. (If
this block is checked, specific justification MUST be provided.)
SECTION 10:

Check “Yes” or “No” to each of the following questions. On a separate
page, provide an explanation for any “Yes” answers that are not
included in the above summary.
Provide justification for why the action is needed, and include information in Section 8 above, such
as who will perform procedures, how they will be performed, frequency, duration, drugs to be used,
dosages, routes of administration, etc. Not all of this information may be needed for every “Yes”
answer. The information you provide in this section is very important in highlighting specific points
of your study that are important considerations for the IACUC in their review process.
YES

NO

Individual(s)
Responsible
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X

Will animals be restrained? (Restraint refers to
immobilization or other restrictions to normal
movement beyond momentary holding for
injections, etc.)

N/A

X

X

X

X

X

X

X

Will animals be fasted?

OVER NIGHT PRIOR
TO SACRIFICE

Are any ANESTHETICS, ANALGESICS, or
TRANQUILIZERS to be used?
Who will administer?...............................................

HEGSTED, O’NEIL,
KEENAN, FRANCIS,
MCCUTCHEON

Are neuromuscular blocking agents to be used?
Who will administer
agents?......................................
How will animals be monitored?
Will surgical procedures be employed? Are they:
Survival
Multiple
Terminal
Who will perform
surgery?.......................................
If survival:
1) Who will be responsible for recovery of the
animals?...................................................................
..
2) Who will maintain post-operative
records?...........
3) Where will records be maintained?
4) Who will provide post-op
analgesics?..................
Note: Survival surgeries must be conducted
aseptically, and major surgical procedures
performed on non-rodent species must be
conducted in a dedicated surgical facility.
Do you anticipate any adverse effects of the
experimental procedures on the animals (e.g., pain,
discomfort, reduced growth, fever, anemia, etc)?
Is death an endpoint in your experimental
procedure? Note: Death as an endpoint refers to
acute toxicity testing, assessment of virulence of
pathogens, neutralization tests for toxins, and
other studies in which animals are not euthanized,
but die as a direct result of the experimental
manipulation.
Are there emergency treatments by the DLAM
veterinary staff that would not be allowed?
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N/A

N/A

N/A

N/A

N/A

X

Are you using wild or exotic species for which
permits are necessary? (ATTACH COPY)
Note: Permits are required for protocol approval.

N/A
HEGSTED, O’NEIL,
KEENAN, FRANCIS,
MCCUTCHEON

Will animals be euthanized during or at the close
of the study?
Who will perform euthanasia?...............

X

X

Will animals be used for antibody production?

N/A

X
X

Will Complete Freund’s Adjuvant be used? If
yes, please justify based on scientific reasons.
Will other adjuvants be used?

N/A
N/A

Will blood be collected?
How often?
3 TIMES
Volume? 400ul two times (retro orbital)
10ml at euthanasia (cardiac puncture)
Who will collect
blood?............................................
Note: Blood equal to 1.5% of the animal’s body
weight per 2 weeks represents the upper approvable
limit, unless scientific justification is provided.

X

HEGSTED, O’NEIL,
KEENAN, FRANCIS,
MCCUTCHEON

SECTION 11:
Animal Management
Individual (or groups of) animals are identified by (i.e. tag, tattoo):
cage cards
Check all applicable below:
CARE OF SICK
DISPOSAL OF DEAD
PEST CONTROL
ANIMALS
ANIMALS
X Call Investigator
X Clinician to Treat
Euthanasia

X Call Investigator
Necropsy
Disposal.
List any special requirements for
disposal?

SECTION 12:

Disposition of Animals

What will be done with any animals at the conclusion of the project?
X

Animals will be euthanized.
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X

Call Investigator
Pesticides OK
No Pesticides

DLAM/LAES has permission to REASSIGN animals to another IACUC-approved
protocol.
TRANSFER animals to the following IACUC-approved protocol(s).
Please list Protocol Number:
OTHER (Please state)

SECTION 13:
Narrative Statement
Federal regulations mandate that you provide written, narrative statements for all projects:
11. that the activities do not unnecessarily duplicate previous experiments. In this statement, include
sources used to make such a determination (e.g., Databases, workshops, expertise in the field,
etc.) If an electronic database was used, include database, years and words searched, and date of
search.
Note: Address the following items only if you indicated project Type B or C in SECTION 9.
12. that you have considered alternatives to procedures producing more than momentary or slight
pain or distress. Indicate what those alternatives were and why they are not appropriate.
13. describing the methods you used to determine that alternatives to such procedures were not
available (Databases, years and words searched, date of search etc.). Put your statements in the
block below.
The effects of high and low GI diets on weight gain; fat accumulation and bone density can
only be analyzed using live animals. Previous studies using glycemic index starch diets did not
allow for maximum weight gain, and did not analyze fat accumulation or variations in bone
density. The Web of Science search system was used with the key words: glycemic index,
insulin sensitivity, rats, resistant starch, amylose, amylopectin, glucose, weight gain, adipose
tissue, and leptin for the years 1984 to present. Search was completed 10/25/2001
The only source of pain for this study will be as a result of the retro orbital bleeding. The
animals will be under general anesthesia during the procedure and should have only mild and
short-term discomfort after recovery. They will be monitored after the procedure for eye
irritation and treated promptly as needed. This method was chosen as the optimum method of
blood collection since there is less chance of self-mutilation at the collection site as in other
recommended methods, including tail and saphaneous vein bleeding. Web of Science search
system was used with the key words: retro orbital bleeding, rats, and blood collection for the
years 1984 to present. Search was completed 10/29/2001.
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SECTION 14:
Investigator Training
In accordance with IACUC policy, all personnel conducting animal-based research must attend a
Rules and Regulations Course and verify their training, experience and skills in the care and use of
the animals and techniques they are responsible for.
List all persons involved in animal care and use for this study below.
RULES AND REGULATIONS TRAINING COURSES
Name

Rules/Regulations Date Attended Species
Date
Training Course
Wet Lab* Attended

Maren Hegsted

X

Training
and
Experience*
*
X
YES

3/8/00

YES
NO

6/1/99

YES
NO

YES

3/9/99

YES
NO

NO
X
YES

11/6/01

YES
NO

NO
X
YES

11/6/01

YES
NO

NO
X
YES

YES
NO

NO
Carol O’Neil

X
YES

X

NO
Mike Keenan

X
YES
NO

Kathleen L McCutcheon

X
YES
NO

Anne R Francis

X
YES

NO
YES

NO
Rania Mekary

11/6/01

X
YES

YES
NO

X
NO

NO

* Exemption based on previous experience with the study species may be obtained by written
request to the IACUC.
** Training/Experience in assigned procedures for this protocol.
Who will train individuals for participation in protocol procedures?
Dr. Maren Hegsted
Dr. Rhett Stout
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Personnel participating in the project that have not attended the Rules and Regulations Course or the
applicable Species Wet Lab, will have six (6) months from the approval date of the project to
complete them.
Rules and Regulations Courses will be held the first Tuesday of every month from 11:00 a.m. until
Noon, in room 1212C, School of Veterinary Medicine. The Wet Labs will be held on the same day
beginning at 1:00 p.m. in the DLAM facility. Please call Ms. Dawn Best-Desjardins at 578-9643 to
sign up for these courses.
SECTION 15:
Occupational Health and Safety
It is the responsibility of the principal investigator to conduct a hazard analysis and risk assessment
to determine if personnel involved directly or indirectly in the study should participate in the
Occupational Health Program administered through DLAM and the Student Health Center.
Will project personnel participate in the Occupational Health Program?
13.
YES
14.
NO
If yes, please name participants below, and have them contact Mr. Rick Ramsey at 578-9644 for
information.
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APPENDIX B:
AMENDMENT TO IACUC (LSU)
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APPENDIX C:
IACUC (PBRC)
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PENNINGTON BIOMEDICAL RESEARCH CENTER
INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE
Dr. David Baker, LSU SVM
PBRC
Dr. Lauri Byerley, PBRC
Dr. Ling Lin, PBRC

Dr. Hans Berthoud, PBRC - Chair

Dr.

Randy

Mynatt,

Mrs. Diane Olinde, Community RepresentativeDr. Matrin Rossmeisl, PBRC
Dr. David A. York, PBRC, Institutional Official Dr. Aamir Zuberi, PBRC

GUIDELINES FOR SUBMISSION OF NEW PROTOCOL FORMS AND EXISTING
PROTOCOL AMENDMENTS FOR IACUC REVIEW (12/01)

NEW PROTOCOL
A new protocol form must be filled out and submitted to the IACUC for approval:
1) to receive formal approval to begin experiments/procedures outlined in a new protocol;
2) if there are changes in major operative procedures in an existing protocol (the protocol is not assigned
a new number); or
3) if there are changes in species in an existing protocol (the protocol is not assigned a new number).
PROTOCOL RENEWAL
All existing protocols are evaluated by the IACUC every three years. The term renewal refers to IACUC
action on a previously approved, but EXPIRING protocol. A new *protocol form must be submitted for a
renewal (for a maximum of up to three years). If renewed by the IACUC, the protocol is not assigned a new
number when renewed.
PROTOCOL AMENDMENT
A protocol may be amended if the original intent of the protocol does not change. Protocol amendments
include:
1)
2)
3)
4)
5)

requests to extend the time remaining on protocols (not to exceed a total of 3 years);
changes in dosage;
changes in animal numbers;
changes in group designations; or
changes in time length of experiments.

A new protocol form is not necessary; instead, simply submit a letter to the IACUC, citing the protocol
number and title, and outlining the change(s) requested.
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INSTRUCTIONS FOR USING ANIMAL CARE AND USE PROTOCOL FORM:
1.

Changes or revisions may frequently be made by the Institutional Animal Care and
Use Committee (IACUC) and this file location will always contain the latest revised
version of the form.

2.

Retrieve the form. Save the file in another location: In the toolbar, select [File] and
select [Save as…] . Give the file any name you prefer.

3.

Each section on the form was created as a table; therefore, if extra space is required
when typing, the vertical space in the text portion of a section will increase as you type.
To begin a new paragraph when typing text, simply hit a hard return [Enter]. If you
desire to indent paragraphs in text typing, use a control tab [Ctrl] [Tab].

4.

After completing the form, you may want to remove excess hard returns between
sections in order to limit the finished protocol form to a minimum number of pages.

5.

Should you encounter any problems while using this form, please contact Nancy, David
York’s office, 3-2577.
(Revised 12/01/01)
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Pennington Biomedical Research Center
PROTOCOL FOR ANIMAL CARE AND USE
Submission Instructions: MUST BE TYPED! (Use additional sheets if necessary and
attach to this form). SUBMIT ORIGINAL plus 10 COPIES to the IACUC Office, Rm.
B1022 (Dr. David York’s office)
SECTION 1: Investigators
Principal Investigator:
Roy J. Martin
Co-Investigator:
David S. Roane

Office Phone:
578-2284
Office Phone:
763-2531

Home Phone:
766-2684
Home Phone:
318 342-1700

Email Address
MartinRJ@pbrc.edu
Email Address
RoaneDS@pbrc.edu

SECTION 2: Project Title (Enter the title of your project in the block below.)
NUTRITION, STRESS AND BODY WEIGHT REGULATION

SECTION 3: Investigator’s Statement reguarding the Assurance for the Humane Care and
Use of Vertebrate Animals.
By signing this form, we agree to abide by Pennington Biomedical Research
Center’s Policy for the Care and Use of Animals. This project will be in accordance with the
NIH “Guide for the Care and Use of Laboratory Animals” (except as explained in the
accompanying protocol), and the PBRC Animal Welfare Assurance on file with the U.S.
Public Health Service.
I further assure the Committee that:
1) I will abide by all federal, state, and local laws and regulations governing the use
of animals in teaching and research.
2) The investigators and technicians are or will be adequately trained to perform the
research techniques required in these studies.
3) I will use the fewest number of animals required to produce the appropriate
statistical power for this study.
4) The research proposed herein is not unnecessarily duplicative of previously
reported research.
5) For those completing Section 13.2 and 13.3: I have reviewed the pertinent
scientific literature and the sources and/or databases as noted in Section 13, and
have found no valid alternative to any procedures described herein which may
cause more than momentary pain or distress, whether it is relieved or not.
Roy J. Martin

Professor

10-31-02

Type Name of Principal Investigator

Title/Rank

Date

Adjunct professor

10-31-02

Principal Investigator Signature
David S. Roane
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Type Name of Co-Investigator

Title/Rank

Date

Co-Principal Investigator Signature
SECTION 4: Animal Species
Species: Rat
Sex:
male
both
Species:
Sex:
male
both

female

female

Strain: Sprague-Dawley rats and Zucker rats
Weight (or age for rodents): 200~250g(SD
rats) 5 weeks (Zucker rats)

either

Strain:
Weight (or age for rodents):

either

Species:Rat
950
Number of animals needed:
Year 1: → 470
Year 2: → 240
Year 3: → 240
TOTAL: → 950
Maximum # needed at one time: 100

Animal housing and veterinary care must be coordinated with Comparative Biology.
Signature of Comparative Biology Representative
(required):

SECTION 5: Abstract Plan of Research/Teaching (Provide a brief layman’s description
of the project. This information will help the animal care staff to understand any conditions
encountered while caring for your animals. This space will expand as you type.)
The overall goals of the present research plan are as follows:
1)identify the neurochemical and physiological mechanisms of stress, hunger, satiety and spontaneous
anorexia associated with maintenance of body weight and composition.
2)identify nutritional interventions that modify or prevent a) weight gain or regain, b) stress-induced and
exercised-induced disruption of homeostasis and behavior in experimental animals.
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SECTION 6: Special Husbandry Requirements
Do your animals have special needs to be addressed by Comparative Biology?
No

Yes

If yes, please complete each section that is different from the standard of care for rodents.
The standard of care is: plastic shoebox, corn cob bedding, rodent chow, ≅21-22°C room
temperature, ≅55% humidity, and tap water.
Humidity: 55 (%)
TEMPERATURE RANGE 21-22o (C)
12:12
LIGHT CYCLE (hours light/hours
dark)
Type: wire hanging
Size: standard
Filter tops required? No
CAGING
Autoclaved?
Changes/week:
BEDDING/LITTER Type:
Sterile:
Tap: Yes
Other:
De-ionized:
Acidified:
WATER
DIET

Special Feeding Requirements: In experiments 9,10, and 11, rats will be tube fed
with a commercial semi-purified diet. Dr. Jun Zhou will train graduate student (Bing
Li) and student work for this type of special feeding procedure.

IF USING WIRE BOTTOM
CAGES, PLEASE
JUSTIFY:
OTHER SPECIAL NEEDS

Food intake and spillage need to be measured during the experiment
period.

SECTION 7: Hazardous Materials Will zoonotic or recombinant, radioactive, or
hazardous chemical agents be PRESENT IN THE ANIMAL ROOM?
Zoonotic/Recombinant Agents
YES

NO

Agent(s):____________
EXEMPT
IBRDS Chairman Signature:

Radioisotopes
YES

NO

Are you certified by the
Radiation Safety
Committee?
YES

NO

Hazardous Chemicals
YES

NO

If yes, you must complete the
Hazardous Chemical Form
(Appendix A)
Compound(s):

Isotope(s):
Note:
If zoonotic (infectious to humans) or recombinant organisms are to be used,
this protocol request must be submitted to the Biohazardous Materials Safety Committee
for approval PRIOR TO CONSIDERATION by the IACUC. Similarly, if hazardous
chemicals are to be used in the animal room, submit the proposal to the Chemical Safety
Committee for prior approval. P.I. MUST PROVIDE health and safety measures for
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animal technicians and facility maintenance personnel. In Standard Operating Procedure
(SOP) form, describe any precautions, procedures, or personal protection required in
handling animals or waste containing listed agents or compounds, or in working in or
around the animal room (including air handling system), and attach a copy of your
SOP(s) to this protocol proposal.

SECTION 8: Type of Project (check the appropriate box)
TYPE A - Pain or distress will not be induced; animals will only be used for
injections, collections, or procedures causing nothing more than minor discomfort; or
will be humanely euthanized prior to induction of pain or distress.
TYPE B - Pain or distress will be relieved by appropriate therapy
TYPE C - Drug intervention for pain or distress would interfere with the protocol. (If
this block is checked, specific justification MUST be provided in the box
below.)

SECTION 9: Summary of Procedures
Answer each of the following in the box provided. If a section is not applicable, indicate not
applicable. Your response in this section should provide the reader with a complete
description of how every animal to be used in this project is to be treated during every
phase of the study. Your target audience is a faculty member from a discipline unrelated to
yours. Do not use jargon. Please include the following information: (each box will expand
as needed, as text is added)
9.1. Rationale: The rationale for using animals. Why should this study be done? What
hypothesis/es will be tested?
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Experimental Series I will focus on analysis of potential glucose sensing genes and proteins in the
CNS. Specifically, these experiments will test the hypotheses that: 1) Glucose sensing gene and
proteins are co-localized within the same cell in the brain much like pancreatic islet cells. 2)
Intracerebroventricular streptozotocin treatment will reduce the number of cells co-localizing
glucose sensing proteins. Experiment 1, 2a, and 2b will address hypotheses 1) and 2) respectively.
Experimental Series II will focus on peptides and neurotransmitters related to ingestive
behavior and their interactions with glucose sensing cells in the brain. Specifically these
experiments will test the hypotheses that: 1) Streptozotocin will decrease glucoprivic induced
hyperphagia, decrease the glucosensing ralted gene expression, and decrease glucosensing related
peptides contents in the brain. 2) Streptozotocin will attenuate the behavioral response to centain
ingestive peptides and neurotransmitters that are glucose related. 3) Streptozotocin will decrease
the in vitro neurotransmitter release stimulated by glucoprivation. 4) Streptozocin will decrease
the hypoglycemia induced by the hypothalamic administration of glibenclamide. Experiment 3,
4a, 4b, 5, and 6 will test these hypotheses respectively.
Experimental Series III will test the hypotheses that glucose-sensing mechanisms in
specialized cells of the brain are altered by obesity, by glycemic state, and by simple states of
hunger and satiety. Three robust models of disrupted energy balance and glucose homeostasis will
be used. Each model has a different etiology. Fatty Zucker rats, over-/underfeeding rats, and
glucose/5-thioglucose intracerebroventricular injected rats will be used in this experiment series.
We will test these rats’ behavioral responsiveness to glucoprivation/glucose excess and correlate
these changes with levels of brain glucosensing genes expression in experiment 7, 8, 9 and 10.
Collectively, these experiments will explicitly test whether specialized glucose sensing
cells in the brain play a role in the physiological control of feeding behavior and glucose
homeostasis.
9.2. Species Selection: How and/or why you selected the animal species indicated?
Most of the basic mechanisms of brain regulation of body weight and energy balance are studied in
rats and mice. In addition, it is more economical to use the smaller species of animals at this level
of investigation. Once a critical factor is identified for body weight regulation it will be tested in
larger species and eventually in human trials after safety concerns are addressed.
9.3. Experimental Design: A complete description of the proposed use of the animals.
Describe the experimental design of the study. Include a list of any physical, chemical
or biological agents (name, dose, volume, route, and frequency) that may be
administered. Tables and outlines are helpful to indicate group assignments and
study progression.
Table 1. Number of animals required
------------------------------------------------------------------------------------------------------------------------Experiment Number of
Justification
number
animals
--------------------------------------------------------------------------------------------------------------------1

50
beta=0.80

Based on power analysis of preliminary data, alpha=0.05,
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2a

60
Empirically based on professional judgment with similar
experiments
2b
60
Empirically based on professional judgment with similar
experiments
3
80
Empirically based on professional judgment with similar
experiments
4a
100
Adequate number for establishing clear dose/ response
relationships
4b
100
Adequate number for establishing clear dose/ response
relationships
5
40
Based on power analysis of preliminary data, alpha=0.05,
beta=0.80
6
80
Empirically based on professional judgment with similar
experiments
7
40 Zucker rats
Empirically based on professional judgment with similar
experiments
8
64
male Zucker rats
Empirically based on professional judgment with similar
experiments
9
60
Empirically based on professional judgment with similar
experiments
10
60
Empirically based on professional judgment with similar
experiments
11
60
Empirically based on professional judgment with similar
experiments
12
48
Empirically based on professional judgment with similar
experiments
13
48
Empirically based on professional judgment with similar
experiments
Total rats number
950
------------------------------------------------------------------------------------------------------------------------Experiment 1. Are cells in the brain expressing the same genes and proteins found in
the islets of Langerhans.
This study will use in situ hybridization and immunohistochemical techniques
to localize cell populations that co-localize components of the pancreatic glucosesensing machinery. Total number of 50 Spraquely-dawley rats will be used. Half
of the rats will be used for in situ hybridization to examine glucosensing gene
expression. The other half will be used for immunohistochemistry to test
glucosensing protein levels
For in situ hybridization, rats will be killed by decapitation. The whole brain
will be collected and snap frozen on dry ice and stored at -80°C until be sectioned
on a cryostat. For immunohistochemistry, rats will be euthanized with an overdose
of pentobarbital and each rat will be perfused transcardially with heparinized,
phosphate buffered saline (~ 150 ml) followed by cold phosphate buffered, 4%
paraformaldehyde at 4° C. The brain is removed and postfixed in a 20%
sucrose/4% paraformaldehyde solution overnight. The brain is then ready for
section on a cryostat.
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Experiment 2. Streptozotocin destruction of CNS glucose sensing elements.
One hundred and twenty Spraque-Dawley rats will be anesthetized as
described in general anesthesia procedure below, and then placed in a stereotaxic
apparatus. Sixty rats will be fitted with third ventricle cannula (experiment 2a) and
the rest will be fitted with 4th ventricle cannula (experiment 2b). The detailed
methods for insertion of cannula are described under the "General method for
brain cannulation” below. Rats will be food deprived for 12 hours prior to injection
of streptozotocin (100ug in 5 ul vehicle) or vehicle(5 ul of a freshly made buffer
containing 120 mM NaCl and 20 mM NaHCO3, pH 7.2-7.4). Streptozotocin or
vehicle will be injected into the 3rd or 4th ventricle by connecting cannula interal
with Gastight syringe though polyethylene tubing. The injection rate will be
1ul/3minutes. The cannulae are then closed and the animal will be placed in a
warmed cage to recover. Each animal is allowed to recover for 4 to 10 days after
streptozotocin injection. After recovery, each animal will be decapitated or
euthanized by an overdose of pentobarbital and perfused (for in situ hybridization
and for immunohistochemistry respectively, as described in experiment 1). The
pattern of staining is then compared between the vehicle and streptozotocin
treated rats.
Experiment 3: Streptozotocin will decrease glucoprivic-induced hyperphagia.
Eighty Spraque-Dawley rats will be treated with streptozotocin or vehicle as
described in experiment 2. We will choose either 3rd or 4th ventricle cannulation
depending on the results of experiment 2. After a 4 to 10 day recovery period, half
of the rats in each group will be evaluated for behavioral response to a glucoprivic
challenge (200 mg/kg 2DG, i.p) and the other half will have saline injection as
control. Food intakes will be measured at the time point of 30, 60, 120, and 240
minutes after injection. This challenge will allow us to determine that the
streptozotocin treatment was effective. Following the behavioral test to a
glucoprivic challenge (3-5 day recovery period), rat will be killed to examine
ingestive relate peptides and their gene expression by immunohistochemistry or in
situ hybridization as described in experiment 1. Distribution of staining for the
ingestive peptides or the respective receptors will be compared between the
vehicle and streptozotocin treated rats.
Experiment 4:
Two hundreds SD rats will be placed 3rd or 4th ventricle cannulae depending
on the results of experiment 2. After 7 to 10 days recovery, the rats will be treated
with streptozotocin or vehicle as described in experiment 2. Behavioral tests will
be conducted 4~7 days after streptozotocin injection. The behavioral tests will
include a glucoprivic challenge, as described in experiment 3, to determine
efficacy of the streptozotocin. We will also use 12 h food deprivation to stimulate
food intake in these rats. The following peptides and neurotransmitters will be
tested on altering deprivation induced feeding in rats treated with streptozotocin.
We also will develop dose-response curves for each of the peptides and
neurotransmitters according to the table below. The injection volume will be 5ul
and the freshly made buffer (120 mM NaCl and 20 mM NaHCO3, pH 7.2-7.4 ) will
be used to prepare the injection solutions. Due to the difficulty of handling such a
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large number of cannulated rats, we will subdivided this experiment in two parts. In
the experiment 4a, we will test GLP-1, Amylin, and Leptin. In the experiment 4b,
we will test NPY, CRH and GABA . One hundred rats (50 for vehicle and 50 for
streptozotocin) will be used in each experiment; each dosage group will have 10
rats. Food intakes will be measured at the time point of 30, 60, 120, and 240
minutes after injection.
------------------------------------------------------------------------------------------------------------------------PEPTIDE
EFFECT
DOSES
------------------------------------------------------------------------------------------------------------------------GLP-1
Suppress food intake
0, 0.5, 1, 5, 10 ug
Amylin
Suppress food intake
0, 1, 10, 25, 100 ug/kg
Leptin
Suppress food intake
0, 1, 10, 25, 100 ug/kg
NPY
Increase food intake
0, 1, 10, 25, 100 ug/kg
CRH
Suppress food intake
0, 1, 10, 25, 100 ug/kg
GABA
Increase food intake
0, 1, 10, 25, 100 ug/kg
------------------------------------------------------------------------------------------------------------------------Experiment 5:
Forty SD rats will be treated with streptozotocin or vehicle as described
above. Seven days after the treatments, brains will be quickly removed by
decapitation, and placed in a slicing block. Based on immunocytochemistry and in
situ hybridization studies in experiment 1, brain areas that express GLUT-2 and
Glucokinase will be dissected, weighed and placed in appropriate chambers of a
Brandel Superfusion 2000 apparatus. Tissues will be superfused at 0.1 ml/min
with Kreb's Ringer bicarbonate buffer (KRB) with the following composition in mM:
NaCl 118.6, KCl 4.8, CaCl2 2.5, KH2PO4 1.2, MgSO47H2O 1.3, NaHCO3 24.6,
glucose 33 and pargyline 0.4, a monoamine oxidase inhibitor. KRB is used to
collect "basal" release. Basal release will be collected for 90 minutes. Then, KRB
containing 10 mM 2-DG will be perfused to stimulate neurotransmitter release
("stimulated" release) for 5 minutes. Stimulated release is carried out to check for
viability of the tissue. The flow rate will be 100 ul/minute. The eluate from each
chamber is collected at 5-minute intervals with a fraction collector. An internal
standard is added to each sample as it is collected. Samples are immediately
frozen on dry ice and stored at -70°C until analysis via HPLC.
Experiment 6:
Eighty SD rats will be fitted with bilateral cannula targeted for drug delivery to
the dorsal aspect of the ventromedial nucleus of the hypothalamus. Following a
seven-day recovery period, half of the animals will be bilaterally injected with of
streptozotocin as decribed in experiment 2, but injection volume will be reduced to
2ul each site. The remaining animals will receive injections of vehicle. Four days
later, half of the animals in each treatment group will be injected with 1 nmol(2ul)
of glibenclamide through each cannula and the remainder will be injected with
solution used for preparation of the glibenclamide (see below). A 30ul blood
sample will be collected by tail bleeding (see “General method for tail bleeding”)
immediately before and every 15 minutes after glibenclamide injection, for a period
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of one hour. Blood glucose will be measured by glucometric analysis.
As glibenclamide has limited aqueous solubility, it will initially be dissolved in
very small quantities of DMSO. The solution will then be brought up to near final
dilutions in a freshly made buffer containing 25 mM NaCO3, 100 mM NaCl, 4 mM
KCl and 1 mM glucose. Final pH will be adjusted to 7.2 with 0.1 N HCl. Control
animals will be injected with the drug vehicle (including DMSO, 0.2 to 10%).
The weakest point of this approach is probably that of injecting each animals
through the VMH cannula twice. Any amount of injection is likely to produce some
cell damage and hence introduce that possibility of artifact. None-the-less, we feel
this is a necessary risk given the poor (or unknown) diffusion capacity of
streptozotocin through the parenchyma of the brain. If streptozotocin was given by
a ventricular route, it might not reach the critical areas in concentration sufficient to
produce meaningful biological results in the area in question.
Experiment 7.
We will kill 20 lean and 20 obese Zucker rats (8 weeks old) and collect brains
for studies of CNS and pancreatic gene expression of proteins involved in glucose
sensing based on results of experiment 1 and 2. Half of the rats in each phenotype
will be used for in situ hybridization to examine glucosensing gene expression.
The other half will be used for immunohistochemistry to test glucosensing protein
levels. The detailed methods for brain tissue collections are the same as in the
experiment 1.
Experiment 8.
Sixty-four male Zucker rats, half lean, half obese and aged 6 weeks, will be
injected glucose. Since we have validated that 2.5 gm of glucose will suppress food
intake in hungry Sprague-Dawley rats and that streptozotocin will attenuate this response,
we will conduct a glucose dose response curve (0, 1.0, 1.5, and 2.5 gm glucose in 0.5 ml
saline solution, i.p.) in both lean and obese rats. Each dosage group will have 8 rats and
each rat will be tested repeatedly at age of 6, 8, 10, and 14 weeks
Experiment 9. Does over- and under- feeding models alter CNS cells of glucose sensing?
Sixty Sprague-Dawley rats, weighing about 250 grams, will be randomly
assigned into four groups (n=15 per group). One group will be ad libitum fed as an
ad lib intake control group; the other three groups will be tube fed. In tube fed
groups, one group (regular fed) will be tube fed 85% of ad lib food intake, the
second group (underfed group) will be tube fed 50% of ad lib food intake, and the
3rd group (overfed group) will be tube fed 150% of ad lib food intake. As tube
feeding 85% of ad libitum food will cause body weight gain similar to ad lib feeding
rats according to our previous study, 85% fed group will be used for normal regular
fed control in tube fed rats for comparison. Four parts of a commercial semipurified diet, which contains 70% polycose, 10% casein, 10% coin oil, 3%
cellulose, and 1% AIN vitamin and mineral mix, will be mixed with three parts of
warm water to make a liquid diet. The rat will be restrained with the right hand and
the feeding tube will be gently introduced through the mouth into the stomach. The
freshly prepared meal (5 ml) will be gently delivered from syringe and then the
tube will be withdrawn. The amount of food delivered to overfed and underfed rats
will be gradually adjusted to the desired level of intake over a period of 3-5 days.
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The rats will receive one-third the daily amount of food, three times daily (07:00,
14:30, and 22:30) for 14 days. Body weight will be recorded daily before the 07:00
feeding.
This model has the advantage of having a controlled rapid alteration of
adipose tissue mass and the up-regulation of either hunger or satiety signals, thus
making it easier to measure changes in gene expression. In addition, since weight
gain or weight loss is produced without changing diet composition and in animals
of the same genetic background, there are fewer confounding factors to consider.
Furthermore, the exact caloric intake, meal size and timing can be controlled,
further reducing variability. At the end of the study, rats will be decapitated, brain
and pancreatic tissues will be removed for RNA and protein extraction. Real-time
PCR and westerns will be used to identify gene expression and proteins that are
altered in positive and negative energy states. The gene expression we target will
be based on results found in the experiment 1 and 2. Specifically those mRNA and
proteins that are reduced or eliminated by streptozotocin treatment.
Experiment 10. Does obesity caused by hyperphagia alter feeding response to
glucoprivation by altering CNS cells of glucose sensing?
Sixty Sprague-Dawley rats, weighing about 250 grams, will be placed 3rd
ventricle cannula (see General method for brain cannulation” below). After 7 to 10
days recovery, the rats will be randomly assigned into two groups (n=30 per
group). One group will be tube fed 85% of ad libitum food and the other group will
be tube fed with 150% of ad libitum food. The amount of ad libitum food will be
determined according to the results of Experiment 9. The diet composition and the
feeding method are the same as those described in Experiment 9. After 14 days
tube feeding, rats in each group will be divided into two subgroups: control and 2DG. Control group will be ICV injected with vehicle (5 ul of a freshly made buffer
containing 120 mM NaCl and 20 mM NaHCO3, pH 7.2-7.4) and 2-DG group will
ICV injected with 2-DG (10ug in 5ul of vehicle). Food intake will be recorded at 1h,
2h, and 4h after ICV injection. All rats will be killed four hours after injection, for
the measurement of glucosensing related gene expression and protein as
described in Experiment 1 and Experiment 9.
Experiment 11. Does energy deficiency caused by underfeeding alter feeding response
to glucose by altering CNS cells of glucose sensing?
Sixty Sprague-Dawley rats, weighing about 250 grams, will be placed 3rd
ventricle cannula (see “General method for brain cannulation” below). After 7 to
10 days recovery, the rats will be randomly assigned into two groups (n=30 per
group). One group will be tube fed 85% of ad libitum food and the other group will
be tube fed with 50% of ad libitum food. The amount of ad libitum food will be
determined according to the results of Experiment 9. The diet composition and the
feeding method are the same as those described in Experiment 9. After 14 days
tube feeding, rats in each group will be divided into two subgroups: control and
glucose. Control group will be ICV injected with vehicle (5 ul of a freshly made
buffer containing 120 mM NaCl and 20 mM NaHCO3, pH 7.2-7.4) and glucose
group will ICV injected with glucose (10ug in 5ul of vehicle). Food intake will be
recorded at 1h, 2h, and 4h after ICV injection. All rats will be killed four hours after
injection, for the measurement of glucosensing related gene expression and
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protein as described in Experiment 1 and Experiment 9.
Experiment 12. Long-term hyperglycemia in brain stem area (including AP/NTS) through
fourth ventricle infusion of glucose.
Forty-eight male SD rats will be will be placed 4th ventricle cannula (see
“General method for brain cannulation” below). Following complete recovery from
surgery (rats will be considered to have recovered with the return to preoperative
food intake level and body weight), an Alzet pump, containing test solution, will
replace in the peritoneal cavity and connected with the brain cannula on each rats
(see “General method for Alzet pump” bellow). The rats will be divided into 4
groups according to the following table. This system will deliver our test solution to
the 4th ventricle areas at a rate of 0.5 ml /hr for 14 days. Food intakes and body
weight will be measured during the experiment period and at the end of
experiment, all rats will be killed for measurements of glucosensing related gene
and protein as described in experiment 1
------------------------------------------------------------------------------------------------------------------------Treatments
Number of Animals
.
------------------------------------------------------------------------------------------------------------------------Control
Mock CSF fluid
12
Experimental
(plus glucose)
5 mM
12
20 mM
12
100 mM
12
.
------------------------------------------------------------------------------------------------------------------------Experiment 13. Long-term hypoglycemia in brain stem (including AP/NTS) through fourth
ventricle infusion of 5-thioglucose.
Forty-eight male SD rats will be will be placed 4th ventricle cannula (see
General method for brain cannulation” below). Following complete recovery from
surgery (rats will be considered to have recovered with the return to preoperative
food intake level and body weight), an Alzet pump, containing test solution, will
replace in the peritoneal cavity and connected with the brain cannula on each rats
(see detailed method for Alzet pump bellow). The rats will be divided into 4 groups
according to the following table. This system will deliver our test solution to the 4th
ventricle areas at a rate of 0.5 ml /hr for 14 days. Food intakes and body weight
will be measured during the experiment period and at the end of experiment, all
rats will be killed for measurements of glucosensing related gene and protein as
described in experiment 1
-----------------------------------------------------------------------------------------------------------------------Treatments
Number of Animals *
-----------------------------------------------------------------------------------------------------------------------Control
Mock CSF fluid
12
Experimental 5-thioglucose
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5.0 mM
20.0 mM
100.0 mM

12
12
12

.

9.4. Number of Animals: How did you arrive at the number of animals to be used. (In
other words, is this number required to (reach) obtain sufficient statistical power, or
necessary as a continual source of tissue harvest for ongoing work, or a limited
number for pilot or feasibility studies, or other.) This may be best accomplished by use
of a table.
The number of animals used in each experiment is based on a power analysis. Since the standard
deviation of the different measurements determines the number of rats to be used in the above
considerations and the standard deviation varies with different measurements, it is necessary that
adjustments be made in the estimate of animals needed on each trial as we gain experience with
some of these measurements. Usually it requires 8-10 rats per treatment group with 3 to 4
treatment groups per study. For the brain cannulation, 12-15 rats per group will be needed. Studies
typically last approximately 6 weeks.
9.5. Non-Surgical Procedures: Describe each procedure to which any animal in any
group may be subjected. Indicate how analgesic, anesthetic, and tranquilizing agents
will be used where appropriate, to minimize discomfort and pain to the animals. It is
advisable that you obtain input from PBRC’s Attending Veterinarian (Dr. David Baker).
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9.6. Surgical Procedures/Ante Mortem Tissue Harvest (complete questions 6 a-i if
animals survive surgery/tissue harvest. Only sections a-f should be completed if nonsurvival surgery/tissue harvest.)
9.6.a) Surgical/ha General method for Alzet pump
The Alzet mini-osmotic pump(Alza, Stanford, CA, model 2002: 0.5ul/hr for 14
rvest
procedures days) will be filled with the appropriate test solution described in each experiment
and placed in 0.9% saline at 37°C overnight. The primed pumps will then be
(describe
placed subcutaneously in the rats under isofluorane anesthesia. A small incision
in detail;
will be made in the scapulae region of the back, where the pump will be placed.
include
Each incision is closed with suture. The combined uses of mini-osmotic pumps
suture
and brain cannulation have been successfully utilized in our lab in the study of
material
obesity. Chronic infusion of test solution into brain will be accomplished by
used):
connecting outlet of the mini-pump to an infusion cannula (designed to project 1
mm beyond the guide cannula tip) through silicone tubing (Baxter/Scientific
Products) filled with test solution. This system will deliver our test solution to the
fourth ventricle at a rate of 0.5 ml /hr for 14 days.
General method for brain cannulation:
Rats will be anaesthetized with Ketamine/Xylazine/Acepromazine mix (80 mg/Kg
Ketamine, 6 mg/Kg Xylazine, 2mg/Kg Acepromazine SQ injection). They will be
placed in the stereotaxic apparatus. An incision will be made along the midline
and periosteum will be scraped from the skull, while a combination of lidocaine
and bupivicaine (1:1 dilution) is infiltrating on the cranium. Site-specific guide
cannula (Plastics One Inc., VA) will be placed. Third ventricle 22 G guide cannula
will be placed using the following coordinates from the bregma: 2.8 mm posterior,
0 mm lateral, 8.1 mm deep. Fourth ventricle 22 G guide cannula will be placed
using the following coordinates from the occipital suture: 2.5 mm posterior, 0 mm
lateral, 4.5 mm deep. VMH 22 G guide cannula will be placed at 13 degrees using
the following coordinates: 2.8mm behind Bregma and 2.8 mm to the right (or left)
of Bregma. The cannula connectors will be fixed to the skull with jewelers screws
and cyanoacrylate gel (plastic One). 31G injectors will extend 1 mm below the
guide cannula.
Placement of ventricular cannula will be verified by measuring angiotensin II
response. After a 5-day recovery period, the rats will be injected angiotensin II
(150ng in 3ul 0.9% saline) through the cannula and those exhibiting a negative
drinking response will be excluded. Placement of site-specific cannula will be
confirmed histologically by injected with 0.25 ul India ink and killed 4 minutes
later. Brains will be fixed in formalin and the location of the injection sites
confirmed histologically. The rats will be allowed to recover from surgery for one
week and then baseline food intakes and body weights will be recorded. Food
intakes and body weights will be recorded through out the experiment period.
General method for tail bleeding:
Blood is collected in hand-held, conscious rats by tail bleeding. A small section
(2-3mm) is nicking from the end of the tail and 30 to 50 ul blood is collected in an
eppendorf tube within less than 2 minutes. A simple gauze will be applied to the
end of the tail to prevent further bleeding.
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9.6.b) Personnel
responsible for:
1. Surgery/Ti
ssue
Harvest

Name

Lab Phone

Home
Phone
267-6950
819-2286
273-8432
216-0439

Email address

9.6.e) Methods of
monitoring
anesthesia
depth (e.g.
monitoring
heart rate,
palpebral
reflex):
9.6.f) Paralytic
agents and
dose (include
methods for
monitoring
anesthetic
depth while
paralyzed):

Moniting 1) Respiratory rate 2) Mucous memberane color 3) Reflexes

Lib@pbrc.edu
763-2531
Bing Li
Zhouj@pbrc.edu
763-2531
Jun Zhou
xix@pbrc.edu
763-2531
Xiaochun Xi
BogackIU@pbrc.edu
763-2531
Iwona
Bogacka
Lib@pbrc.edu
267-6950
763-2531
2. Anesthesia Bing Li
Zhouj@pbrc.edu
819-2286
763-2531
Jun Zhou
xix@pbrc.edu
273-8432
763-2531
Xiaochun Xi
BogackIU@pbrc.edu
216-0439
763-2531
Iwona
Bogacka
Lib@pbrc.edu
267-6950
763-2531
3. Post-op
Bing Li
Zhouj@pbrc.edu
819-2286
763-2531
Care
Jun Zhou
xix@pbrc.edu
273-8432
763-2531
Xiaochun Xi
BogackIU@pbrc.edu
216-0439
763-2531
Iwona
Bogacka
PBRC Comparative biology surgery room
9.6.c) Location
where
surgery/tissu
e harvest is
performed:
#1 - Ketamine/acepromazine/xylazine
9.6.d) Anesthesia:
Drug:
#2 - 0.25%Bupivacaine/Lidocaine
(Duplicate
table if more
#1 - 80/2.0/6.0mg/kg
Dose:
than one
#2 - 2.5~12.5 mg/kg or 1:1 dilution
drug. Rodent Frequency:
#1 - Once
cocktail
#2 - Once
would be
#1 - SQ
Route of
considered
Administratio #2 - infiltrating the periosteum at the site where
one drug.)
trephining will occur
n:
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9.6.g) Post-op care
(Describe
post-op care
provided
including
surveillance.):
9.6.h) Post-op
analgesia
regimen
(Procedures
known to
cause
postoperative
pain in
humans
should be
considered
painful to the
subject
animal):
9.6.i) Are there
more than
one survival
surgery
procedures
performed on
a single
animal?

1. First 24 hours:
2. Second 24
hours:
3. Thereafter:
Drug:
Dose:
Frequency
Route of
Administratio
n:

YES
NO

put rats in a warm place and observe rats until they
are conscious
obeserve rat's behavior, body weight, and food
intakes
obeserve rat's behavior, body weight, and food
intakes
Tylenol
110~300 mg/kg body weight (1:1000 dilution)
in drinking water for 4 to 5 days
oral

If yes, please provide justification. The combined use of
mini-osmotic pumps and brain cannulation can chronicly
infusion of test solution into certain site of the brain.

9.7. Euthanasia: What method or agent will be used to sacrifice the animals? Include
dosage and route of administration.
Method:
Animals will be euthanized at the end of the experiment by rapid
decapitation. Due to the nature of the biochemical measurements to be
performed, this must be carried out without anesthesia. Decapitation will
be carried out by individuals who have had previous training and
experience with the procedure and can minimize stress to the animal.
Drug:
Route of Administration:
Who will perform euthanasia?
Jun Zhou, Iwona Bogacka, Bing Li, Xiaochu Xi and Kichoon Lee

SECTION 10:
questions.

Procedure Checklist. Check “Yes” or “No” to each of the following
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Provide justification for why the action is needed. The information you provide in this
section is very important in highlighting specific points of your study that are important
considerations for the IACUC in their review process.
Response to Question
Question
YES NO
No
← .. Will animals be restrained? (Restraint refers to
immobilization or other restrictions to normal
movement beyond momentary holding for
injections, etc.)
If so, how?
................................................ →
Who is the individual responsible? ................
→
Yes
← .. Will animals be fasted?
50% feeding for 14 days
Is yes, for how long? ......................................
→
Yes
← .. Do you anticipate any adverse effects of the
experimental procedures on the animals?
If yes, list the conditions (e.g., pain, discomfort,
weight loss
% weight loss, maximum tumor size, fever,
miminum packed cell volume, etc) ..................
→
No
Not Applicable
← .. Is death an endpoint in your experimental
procedure? Note: Death as an endpoint refers
to acute toxicity testing, assessment of virulence
of pathogens, neutralization tests for toxins, and
other studies in which animals are not
euthanized, but die as a direct result of the
experimental manipulation.
No
← .. Are there emergency treatments by the
Comparative Biology veterinary staff that would
not be allowed?
If yes, list the treatments. ...............................
→
No
Not Applicable
← .. Are you using wild or exotic species for which
permits are necessary? (ATTACH COPY)
Note: Permits are required for protocol approval.
No
Not Applicable
←...Will animals be used for antibody production?
No
← .. Will Complete Freund’s Adjuvant be used?
If yes, please justify based on scientific reasons.
→
No
← .. Will other adjuvants be used?
If yes, please specify. .....................................
→
Yes
← ..Will blood be collected? If yes: (Note: Blood
equal to 1.5% of the animal’s body weight per 2
weeks represents the upper approvable limit,
unless scientific justification is provided.)
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How often? .........................................................
... →
Volume? .........................................................
... →
Who will collect blood? ...................................... →

Once or twice depending on
particular experiment
0.05ml for tail bleeding
Jun Zhou, Iwona Bogaka,
Xiaochun Xi, Kichoon Lee, and
Bing Li

SECTION 11: Animal Management
Cage card
11.a) Individual (or groups of) animals are identified by (i.e. tag,
tattoo):
11.b) Check all applicable below:
CARE OF SICK ANIMALS
DISPOSAL OF DEAD
PEST CONTROL
ANIMALS
Call Investigator
Call Investigator
Call Investigator
Clinician to Treat
Necropsy
Pesticides OK
Euthanasia
Disposal. List any special
No Pesticides
requirements for
disposal?

SECTION 12:
Disposition of Animals (What will be done with any animals at the
conclusion of the project? Check the appropriate box.)
Animals will be euthanized.
Comparative Biology has permission to REASSIGN animals to another IACUCapproved protocol.
TRANSFER animals to the following IACUC-approved protocol(s). Protocol
Number:
OTHER (Please state):

SECTION 13:
Narrative Statement
Federal regulations mandate that you provide written, narrative statements for all
projects:
13.1. that the activities do not unnecessarily duplicate previous experiments. In this
statement, include sources used to make such a determination (e.g., Databases,
workshops, expertise in the field, etc
Source:Electronic database
If your source is an electronic database(s), complete the following boxes.
Date Search Completed: 10-31-02
Database(s) Searched: Medline
Keywords: obesity, food intake, satiety peptides, streptozotocin, glucose signaling, brain,
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central nervous system, brain metabolism; attendance at scientific meetings where discussions
of regulation of food intake and obesity are held.
Years covered in search: 1966~ present
Note: Answer 13.2 and 13.3 if you indicated Type B or C in Section 8.
13.2. that you have considered alternatives to procedures producing more than
momentary or slight pain or distress. Indicate what those alternatives were and why
they are not appropriate.
there are no alternatives to the procedures in this proposal
13.3. describing the methods you used to determine that alternatives to such
procedures were not available. Put your statements in the block below.
Source: Electronic database
If your source is an electronic database(s), complete the following boxes.
Date Search Completed: 10-31-02
Database Searched: Medline
Keywords: obesity, food intake, satiety peptides, streptozotocin, glucose signaling, brain,
central nervous system, brain metabolism; attendance at scientific meetings where discussions
of regulation of food intake and obesity are held.
Years covered in search: 1966~present

SECTION 14: Investigator Training
In accordance with IACUC policy, all personnel conducting animal-based research must
attend a Rules and Regulations Course and verify their training, experience and skills in the
care and use of the animals and techniques they are responsible for.
List all persons involved in animal care and use for this study below.
Training and
Name
Experience?
David S. Roane
YES
NO
Jun Zhou
YES
NO
Iwona Bogacka
YES
NO
Bing Li/Xiaochun Xi
YES
NO

If no, who will do
training?

NOTE: All personnel must complete Comparative Biology’s training course in order to have
access to Comparative Biology.
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APPENDIX A
Hazardous Chemical Form
for Chemical Use in Animal Rooms
This form should be completed for all studies in which hazardous agents (e.g., toxic chemicals, or
carcinogens) are to be administered to animals that are expected to survive following exposure. A
separate form must be submitted for each hazardous agent used. This form must be approved prior to
starting a study.
INVESTIGATOR:
PROTOCOL#: _________

PHONE:

IACUC

Compound to be administered (please attach MSDS):
Site of compound dose preparation and brief description of containment (safety measures including
hood, gloves, etc.):
Concentration administered:
Location of compound storage and conditions of storage:
Degree of health hazard to humans (circle the most appropriate number):
LOW 1

2

3

4

1 = no special precautions required
precautions required

5

HIGH
5 = extreme

Assays/Assessment to determine exposure to animal or personnel:
Species to be used:
__________________________

Strain:

Route of administration:
___________________________

Dose:

Duration of administration:
Note the anticipated morbidity (

%) and mortality (

%) if known.

Length of time the animals and/or their environment must be considered hazardous following
exposure:
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Maximum number of exposed animals that will be maintained at one time:
Indicate the experiment endpoint:
The following personal protective equipment must be used in the room:
Lab coat/Coveralls
NIOSH Certified Dust Mask Fitted Respirator with HEPA filters
Shoe covers/booties Disposable gloves
Latex
Nitrile gloves
Other:
______________________________________________________
NOTE: Short pants, skirts, and dresses may not be worn in the animal room.
Other relevant information or procedures: include 1) additional precautions, 2) emergency treatments
for exposed personnel, 3) decontamination procedures for equipment, 4) housing areas, 5) personnel,
6) how to determine if personnel are or are not exposed:
Is the compound retained in the animal tissue?

Yes

No (If no, please justify.)

Animal carcasses must be disposed of in the following manner:

Do animals treated with the compound excrete active compounds or metabolites in urine, feces, or
other?
Yes
No (If no, please justify.)
Contaminated feed, water, bedding, and other waste must be disposed of in the following manner:

Investigator:
Chemical Safety Committee approval:
IACUC approval:

Date:
Date:
Date:
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APPENDIX D:
AMENDMENT TO IACUC (PBRC)
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APPENDIX E:
EXPERIMENT ONE RESULTS
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EXPERIMENT ONE RESULTS
As mentioned earlier, the results of experiment one were flawed due to
uncontrollable environmental conditions and inefficient supervision of laboratory
systems; therefore, the results of experiment one were not discussed in earlier chapters.
In this section, the results presented below will represent only that of experiment one.
According to written records by the researcher, days 5-8 of the experiment took
place during the most critical time of the category 4 hurricane, Hurricane Lili, in October
2002. In the course of Hurricane Lili, the university was closed and the public was
strongly advised to remain within their homes; however, the animals were continued to
be fed and weighed and activity was recorded throughout this time. In spite of the effort
to maintain experiment protocol, the expected results of the activity-based anorexia
(ABA) model did not occur. The ABA animals did not progressively lose weight (Figure
13), eat less (Figure 14), or run more (Figure 15) as the experiment continued; therefore,
the experiment terminated when the animals of the ABA group gained and maintained
body weight.
Nevertheless, it is not believed that the experiment protocol failed to produce the
ABA results. Rather, it is alleged that the results did not take place due to the
malfunctioning of the automated lighting system. Because there was an outage of
electricity during these critical days of the hurricane, the lights in the laboratory did not
turn off automatically. Therefore, it is believed that because rats are nocturnal animals,
the continuous light cycle interfered with the ABA model. The animals did not
excessively run on the running wheels; thus, they did not develop a suppression in food
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Figure 13. Body Weight (Experiment One)
Note: NR=non-running, R=running, AL=ad libitum, RF=restricted- feeding; day 0
represents the start of the experiment
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Figure 14. Food Intake (Restricted-Feeding)
Note: NR=non-running, R=running, RF=restricted-feeding; day 1 represents the first
one 90- min meal period; values are in grams per day

141

4000
3500
3000
2500
2000
1500
1000
500
0
.8-9
.9-1
0
.1011
.1112
.1213
.1314

.6-7
.7-8

.4-5
.5-6

.2-3
.3-4

R/AL
R/RF

.0-1
.1-2

Number of Revolutions per Day

Wheel Running

Days

Figure 15. Wheel Running (Experiment One)
Note: R=running, RF=restricted- feeding; day 0-1 represents the first 22hr running
period; values are in number of revolutions per day

intake. Because these two essential characteristics of ABA were not demonstrated, the
ABA animals survived the ABA model.
The results of this study indicated that the light and dark cycle is very crucial to
the ABA model. In addition, it further supports the requirement for elevated activity, and
accordingly food intake suppression, to develop activity-anorexia. Without the 12 hour
light and dark cycles, the ABA animals will run at a rate comparable to animals exposed
to running wheels and fed an ad libitum diet and eat at the amount comparable, if not
more, to sedentary restricted- fed animals.
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